Project
Mucociliary differentiation, bronchial epithelial cells, human (Ross 2007)
Navigation
Downloads
Results for GLI3
Z-value: 1.39
Motif logo
Transcription factors associated with GLI3
| Gene Symbol | Gene ID | Gene Info |
|---|---|---|
|
GLI3
|
ENSG00000106571.8 | GLI family zinc finger 3 |
Activity-expression correlation:
| Gene | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| GLI3 | hg19_v2_chr7_-_42276612_42276782 | 0.52 | 3.4e-03 | Click! |
Activity profile of GLI3 motif
Sorted Z-values of GLI3 motif
| Promoter | Log-likelihood | Transcript | Gene | Gene Info |
|---|---|---|---|---|
| chr19_-_51456344 | 7.48 |
ENST00000336334.3
ENST00000593428.1 |
KLK5
|
kallikrein-related peptidase 5 |
| chr19_-_51456321 | 7.41 |
ENST00000391809.2
|
KLK5
|
kallikrein-related peptidase 5 |
| chr20_+_62327996 | 7.01 |
ENST00000369996.1
|
TNFRSF6B
|
tumor necrosis factor receptor superfamily, member 6b, decoy |
| chr1_-_153433120 | 6.82 |
ENST00000368723.3
|
S100A7
|
S100 calcium binding protein A7 |
| chr19_-_51456198 | 6.42 |
ENST00000594846.1
|
KLK5
|
kallikrein-related peptidase 5 |
| chr10_+_88718397 | 6.01 |
ENST00000372017.3
|
SNCG
|
synuclein, gamma (breast cancer-specific protein 1) |
| chr10_+_88718314 | 5.98 |
ENST00000348795.4
|
SNCG
|
synuclein, gamma (breast cancer-specific protein 1) |
| chr18_+_21529811 | 5.88 |
ENST00000588004.1
|
LAMA3
|
laminin, alpha 3 |
| chr22_+_31489344 | 5.45 |
ENST00000404574.1
|
SMTN
|
smoothelin |
| chr22_+_31488433 | 5.27 |
ENST00000455608.1
|
SMTN
|
smoothelin |
| chr19_-_51472031 | 5.15 |
ENST00000391808.1
|
KLK6
|
kallikrein-related peptidase 6 |
| chr1_+_45205498 | 5.02 |
ENST00000372218.4
|
KIF2C
|
kinesin family member 2C |
| chr1_+_150522222 | 4.98 |
ENST00000369039.5
|
ADAMTSL4
|
ADAMTS-like 4 |
| chr13_-_60738003 | 4.75 |
ENST00000400330.1
ENST00000400324.4 |
DIAPH3
|
diaphanous-related formin 3 |
| chr1_+_152956549 | 4.42 |
ENST00000307122.2
|
SPRR1A
|
small proline-rich protein 1A |
| chr12_-_57634475 | 4.35 |
ENST00000393825.1
|
NDUFA4L2
|
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 4-like 2 |
| chr1_+_183155373 | 4.32 |
ENST00000493293.1
ENST00000264144.4 |
LAMC2
|
laminin, gamma 2 |
| chr4_-_57524061 | 4.19 |
ENST00000508121.1
|
HOPX
|
HOP homeobox |
| chr15_+_90728145 | 3.90 |
ENST00000561085.1
ENST00000379122.3 ENST00000332496.6 |
SEMA4B
|
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4B |
| chr7_-_24797546 | 3.86 |
ENST00000414428.1
ENST00000419307.1 ENST00000342947.3 |
DFNA5
|
deafness, autosomal dominant 5 |
| chr11_+_69061594 | 3.65 |
ENST00000441339.2
ENST00000308946.3 ENST00000535407.1 |
MYEOV
|
myeloma overexpressed |
| chr1_+_45205478 | 3.51 |
ENST00000452259.1
ENST00000372224.4 |
KIF2C
|
kinesin family member 2C |
| chr1_-_152386732 | 3.44 |
ENST00000271835.3
|
CRNN
|
cornulin |
| chr2_+_102928009 | 3.39 |
ENST00000404917.2
ENST00000447231.1 |
IL1RL1
|
interleukin 1 receptor-like 1 |
| chr13_-_20806440 | 3.37 |
ENST00000400066.3
ENST00000400065.3 ENST00000356192.6 |
GJB6
|
gap junction protein, beta 6, 30kDa |
| chr19_+_2096868 | 3.35 |
ENST00000395296.1
ENST00000395301.3 |
IZUMO4
|
IZUMO family member 4 |
| chr12_-_125348329 | 3.15 |
ENST00000546215.1
ENST00000415380.2 ENST00000261693.6 ENST00000376788.1 ENST00000545493.1 |
SCARB1
|
scavenger receptor class B, member 1 |
| chr9_+_35673853 | 3.06 |
ENST00000378357.4
|
CA9
|
carbonic anhydrase IX |
| chr1_+_152881014 | 3.04 |
ENST00000368764.3
ENST00000392667.2 |
IVL
|
involucrin |
| chr21_-_45079341 | 3.01 |
ENST00000443485.1
ENST00000291560.2 |
HSF2BP
|
heat shock transcription factor 2 binding protein |
| chr12_-_52845910 | 3.01 |
ENST00000252252.3
|
KRT6B
|
keratin 6B |
| chr1_-_200589859 | 3.00 |
ENST00000367350.4
|
KIF14
|
kinesin family member 14 |
| chr4_+_17812525 | 2.98 |
ENST00000251496.2
|
NCAPG
|
non-SMC condensin I complex, subunit G |
| chr17_+_15848231 | 2.98 |
ENST00000304222.2
|
ADORA2B
|
adenosine A2b receptor |
| chr6_-_4135825 | 2.97 |
ENST00000380118.3
ENST00000413766.2 ENST00000361538.2 |
ECI2
|
enoyl-CoA delta isomerase 2 |
| chr1_-_47407097 | 2.95 |
ENST00000457840.2
|
CYP4A11
|
cytochrome P450, family 4, subfamily A, polypeptide 11 |
| chr7_-_41742697 | 2.92 |
ENST00000242208.4
|
INHBA
|
inhibin, beta A |
| chr19_-_19051993 | 2.81 |
ENST00000594794.1
ENST00000355887.6 ENST00000392351.3 ENST00000596482.1 |
HOMER3
|
homer homolog 3 (Drosophila) |
| chrX_+_17755563 | 2.81 |
ENST00000380045.3
ENST00000380041.3 ENST00000380043.3 ENST00000398080.1 |
SCML1
|
sex comb on midleg-like 1 (Drosophila) |
| chr1_+_150521876 | 2.77 |
ENST00000369041.5
ENST00000271643.4 ENST00000538795.1 |
ADAMTSL4
AL356356.1
|
ADAMTS-like 4 Protein LOC100996516 |
| chr13_-_60737898 | 2.76 |
ENST00000377908.2
ENST00000400319.1 ENST00000400320.1 ENST00000267215.4 |
DIAPH3
|
diaphanous-related formin 3 |
| chr19_+_676385 | 2.75 |
ENST00000166139.4
|
FSTL3
|
follistatin-like 3 (secreted glycoprotein) |
| chr3_+_136537911 | 2.74 |
ENST00000393079.3
|
SLC35G2
|
solute carrier family 35, member G2 |
| chr12_-_54813229 | 2.73 |
ENST00000293379.4
|
ITGA5
|
integrin, alpha 5 (fibronectin receptor, alpha polypeptide) |
| chr19_+_45418067 | 2.67 |
ENST00000589078.1
ENST00000586638.1 |
APOC1
|
apolipoprotein C-I |
| chr7_-_24797032 | 2.66 |
ENST00000409970.1
ENST00000409775.3 |
DFNA5
|
deafness, autosomal dominant 5 |
| chr15_+_67430339 | 2.65 |
ENST00000439724.3
|
SMAD3
|
SMAD family member 3 |
| chr6_-_133084580 | 2.65 |
ENST00000525270.1
ENST00000530536.1 ENST00000524919.1 |
VNN2
|
vanin 2 |
| chr8_+_31497271 | 2.59 |
ENST00000520407.1
|
NRG1
|
neuregulin 1 |
| chr11_-_2170786 | 2.56 |
ENST00000300632.5
|
IGF2
|
insulin-like growth factor 2 (somatomedin A) |
| chr12_-_125348448 | 2.55 |
ENST00000339570.5
|
SCARB1
|
scavenger receptor class B, member 1 |
| chr10_-_90712520 | 2.55 |
ENST00000224784.6
|
ACTA2
|
actin, alpha 2, smooth muscle, aorta |
| chr19_+_45417812 | 2.44 |
ENST00000592535.1
|
APOC1
|
apolipoprotein C-I |
| chr7_-_128045984 | 2.36 |
ENST00000470772.1
ENST00000480861.1 ENST00000496200.1 |
IMPDH1
|
IMP (inosine 5'-monophosphate) dehydrogenase 1 |
| chr12_-_13529642 | 2.34 |
ENST00000318426.2
|
C12orf36
|
chromosome 12 open reading frame 36 |
| chr19_-_44285401 | 2.30 |
ENST00000262888.3
|
KCNN4
|
potassium intermediate/small conductance calcium-activated channel, subfamily N, member 4 |
| chr19_+_45417921 | 2.30 |
ENST00000252491.4
ENST00000592885.1 ENST00000589781.1 |
APOC1
|
apolipoprotein C-I |
| chr6_-_2903514 | 2.29 |
ENST00000380698.4
|
SERPINB9
|
serpin peptidase inhibitor, clade B (ovalbumin), member 9 |
| chr19_+_45417504 | 2.27 |
ENST00000588750.1
ENST00000588802.1 |
APOC1
|
apolipoprotein C-I |
| chr20_+_3776371 | 2.23 |
ENST00000245960.5
|
CDC25B
|
cell division cycle 25B |
| chr2_+_10262442 | 2.22 |
ENST00000360566.2
|
RRM2
|
ribonucleotide reductase M2 |
| chr17_-_76899275 | 2.22 |
ENST00000322630.2
ENST00000586713.1 |
DDC8
|
Protein DDC8 homolog |
| chr22_+_46692638 | 2.20 |
ENST00000454366.1
|
GTSE1
|
G-2 and S-phase expressed 1 |
| chr9_-_139891165 | 2.20 |
ENST00000494426.1
|
CLIC3
|
chloride intracellular channel 3 |
| chr17_-_76921459 | 2.19 |
ENST00000262768.7
|
TIMP2
|
TIMP metallopeptidase inhibitor 2 |
| chr2_+_65215604 | 2.18 |
ENST00000531327.1
|
SLC1A4
|
solute carrier family 1 (glutamate/neutral amino acid transporter), member 4 |
| chr16_-_84538218 | 2.09 |
ENST00000562447.1
ENST00000565765.1 ENST00000535580.1 ENST00000343629.6 |
TLDC1
|
TBC/LysM-associated domain containing 1 |
| chr1_+_28206150 | 2.08 |
ENST00000456990.1
|
THEMIS2
|
thymocyte selection associated family member 2 |
| chr6_-_105627735 | 2.06 |
ENST00000254765.3
|
POPDC3
|
popeye domain containing 3 |
| chr10_-_134145321 | 2.05 |
ENST00000368625.4
ENST00000368619.3 ENST00000456004.1 ENST00000368620.2 |
STK32C
|
serine/threonine kinase 32C |
| chr11_-_119187826 | 2.04 |
ENST00000264036.4
|
MCAM
|
melanoma cell adhesion molecule |
| chr5_-_39270725 | 2.04 |
ENST00000512138.1
ENST00000512982.1 ENST00000540520.1 |
FYB
|
FYN binding protein |
| chr6_+_31465849 | 2.04 |
ENST00000399150.3
|
MICB
|
MHC class I polypeptide-related sequence B |
| chr20_+_3776936 | 2.03 |
ENST00000439880.2
|
CDC25B
|
cell division cycle 25B |
| chr1_-_26232951 | 2.03 |
ENST00000426559.2
ENST00000455785.2 |
STMN1
|
stathmin 1 |
| chr11_-_2160180 | 2.03 |
ENST00000381406.4
|
IGF2
|
insulin-like growth factor 2 (somatomedin A) |
| chr17_+_17942684 | 2.02 |
ENST00000376345.3
|
GID4
|
GID complex subunit 4 |
| chr19_-_35992780 | 2.02 |
ENST00000593342.1
ENST00000601650.1 ENST00000408915.2 |
DMKN
|
dermokine |
| chr2_-_208031542 | 2.00 |
ENST00000423015.1
|
KLF7
|
Kruppel-like factor 7 (ubiquitous) |
| chr1_+_3388181 | 1.95 |
ENST00000418137.1
ENST00000413250.2 |
ARHGEF16
|
Rho guanine nucleotide exchange factor (GEF) 16 |
| chr2_-_241080069 | 1.94 |
ENST00000319460.1
|
OTOS
|
otospiralin |
| chr11_+_69931519 | 1.94 |
ENST00000316296.5
ENST00000530676.1 |
ANO1
|
anoctamin 1, calcium activated chloride channel |
| chr19_-_11689752 | 1.93 |
ENST00000592659.1
ENST00000592828.1 ENST00000218758.5 ENST00000412435.2 |
ACP5
|
acid phosphatase 5, tartrate resistant |
| chr6_+_31465892 | 1.89 |
ENST00000252229.6
ENST00000427115.1 |
MICB
|
MHC class I polypeptide-related sequence B |
| chr3_-_196756646 | 1.89 |
ENST00000439320.1
ENST00000296351.4 ENST00000296350.5 |
MFI2
|
antigen p97 (melanoma associated) identified by monoclonal antibodies 133.2 and 96.5 |
| chr1_-_85358850 | 1.88 |
ENST00000370611.3
|
LPAR3
|
lysophosphatidic acid receptor 3 |
| chr20_+_814377 | 1.85 |
ENST00000304189.2
ENST00000381939.1 |
FAM110A
|
family with sequence similarity 110, member A |
| chr9_-_113800341 | 1.85 |
ENST00000358883.4
|
LPAR1
|
lysophosphatidic acid receptor 1 |
| chr19_-_2041159 | 1.84 |
ENST00000589441.1
|
MKNK2
|
MAP kinase interacting serine/threonine kinase 2 |
| chr6_+_24775641 | 1.84 |
ENST00000378054.2
ENST00000476555.1 |
GMNN
|
geminin, DNA replication inhibitor |
| chr11_-_64646086 | 1.82 |
ENST00000320631.3
|
EHD1
|
EH-domain containing 1 |
| chrX_-_100914781 | 1.81 |
ENST00000431597.1
ENST00000458024.1 ENST00000413506.1 ENST00000440675.1 ENST00000328766.5 ENST00000356824.4 |
ARMCX2
|
armadillo repeat containing, X-linked 2 |
| chr7_+_130131907 | 1.77 |
ENST00000223215.4
ENST00000437945.1 |
MEST
|
mesoderm specific transcript |
| chr2_-_85636928 | 1.77 |
ENST00000449030.1
|
CAPG
|
capping protein (actin filament), gelsolin-like |
| chr6_+_43739697 | 1.77 |
ENST00000230480.6
|
VEGFA
|
vascular endothelial growth factor A |
| chr20_-_1306351 | 1.77 |
ENST00000381812.1
|
SDCBP2
|
syndecan binding protein (syntenin) 2 |
| chr20_+_18568537 | 1.74 |
ENST00000377452.3
|
DTD1
|
D-tyrosyl-tRNA deacylase 1 |
| chr18_+_56530136 | 1.71 |
ENST00000591083.1
|
ZNF532
|
zinc finger protein 532 |
| chr11_-_65667884 | 1.71 |
ENST00000448083.2
ENST00000531493.1 ENST00000532401.1 |
FOSL1
|
FOS-like antigen 1 |
| chr14_+_24099318 | 1.71 |
ENST00000432832.2
|
DHRS2
|
dehydrogenase/reductase (SDR family) member 2 |
| chrX_+_135229600 | 1.69 |
ENST00000370690.3
|
FHL1
|
four and a half LIM domains 1 |
| chr9_-_34458531 | 1.68 |
ENST00000379089.1
ENST00000379087.1 ENST00000379084.1 ENST00000379081.1 ENST00000379080.1 ENST00000422409.1 ENST00000379078.1 ENST00000445726.1 ENST00000297620.4 |
FAM219A
|
family with sequence similarity 219, member A |
| chr20_-_6104191 | 1.68 |
ENST00000217289.4
|
FERMT1
|
fermitin family member 1 |
| chr4_+_77172847 | 1.68 |
ENST00000515604.1
ENST00000539752.1 ENST00000424749.2 |
FAM47E
FAM47E-STBD1
FAM47E
|
uncharacterized protein LOC100631383 FAM47E-STBD1 readthrough family with sequence similarity 47, member E |
| chr7_-_4923259 | 1.67 |
ENST00000536091.1
|
RADIL
|
Ras association and DIL domains |
| chr7_-_4923315 | 1.67 |
ENST00000399583.3
|
RADIL
|
Ras association and DIL domains |
| chr17_-_43025005 | 1.66 |
ENST00000587309.1
ENST00000593135.1 ENST00000339151.4 |
KIF18B
|
kinesin family member 18B |
| chr1_+_44399466 | 1.63 |
ENST00000498139.2
ENST00000491846.1 |
ARTN
|
artemin |
| chr14_+_105212297 | 1.63 |
ENST00000556623.1
ENST00000555674.1 |
ADSSL1
|
adenylosuccinate synthase like 1 |
| chr19_-_42931567 | 1.62 |
ENST00000244289.4
|
LIPE
|
lipase, hormone-sensitive |
| chr5_-_157002775 | 1.62 |
ENST00000257527.4
|
ADAM19
|
ADAM metallopeptidase domain 19 |
| chr9_-_114937543 | 1.61 |
ENST00000374264.2
ENST00000374263.3 |
SUSD1
|
sushi domain containing 1 |
| chr10_+_17270214 | 1.60 |
ENST00000544301.1
|
VIM
|
vimentin |
| chr14_-_39572345 | 1.60 |
ENST00000548032.2
ENST00000556092.1 ENST00000557280.1 ENST00000545328.2 ENST00000553970.1 |
SEC23A
|
Sec23 homolog A (S. cerevisiae) |
| chr7_-_97501706 | 1.60 |
ENST00000455086.1
ENST00000453600.1 |
ASNS
|
asparagine synthetase (glutamine-hydrolyzing) |
| chr14_-_39572279 | 1.60 |
ENST00000536508.1
|
SEC23A
|
Sec23 homolog A (S. cerevisiae) |
| chr13_+_32889605 | 1.60 |
ENST00000380152.3
ENST00000544455.1 ENST00000530893.2 |
BRCA2
|
breast cancer 2, early onset |
| chr17_+_36584662 | 1.60 |
ENST00000431231.2
ENST00000437668.3 |
ARHGAP23
|
Rho GTPase activating protein 23 |
| chr20_-_6103666 | 1.59 |
ENST00000536936.1
|
FERMT1
|
fermitin family member 1 |
| chr20_-_44420507 | 1.59 |
ENST00000243938.4
|
WFDC3
|
WAP four-disulfide core domain 3 |
| chr6_-_33756867 | 1.57 |
ENST00000293760.5
|
LEMD2
|
LEM domain containing 2 |
| chr10_-_116164239 | 1.56 |
ENST00000419268.1
ENST00000304129.4 ENST00000545353.1 |
AFAP1L2
|
actin filament associated protein 1-like 2 |
| chr3_-_59035673 | 1.56 |
ENST00000491845.1
ENST00000472469.1 ENST00000471288.1 ENST00000295966.7 |
C3orf67
|
chromosome 3 open reading frame 67 |
| chr16_+_30194916 | 1.56 |
ENST00000570045.1
ENST00000565497.1 ENST00000570244.1 |
CORO1A
|
coronin, actin binding protein, 1A |
| chr4_-_111119804 | 1.55 |
ENST00000394607.3
ENST00000302274.3 |
ELOVL6
|
ELOVL fatty acid elongase 6 |
| chr17_+_39969183 | 1.55 |
ENST00000321562.4
|
FKBP10
|
FK506 binding protein 10, 65 kDa |
| chr15_-_64665911 | 1.54 |
ENST00000606793.1
ENST00000561349.1 ENST00000560278.1 |
CTD-2116N17.1
|
Uncharacterized protein |
| chr20_-_1306391 | 1.54 |
ENST00000339987.3
|
SDCBP2
|
syndecan binding protein (syntenin) 2 |
| chr4_-_177713788 | 1.54 |
ENST00000280193.2
|
VEGFC
|
vascular endothelial growth factor C |
| chr7_-_97501411 | 1.53 |
ENST00000437628.1
|
ASNS
|
asparagine synthetase (glutamine-hydrolyzing) |
| chr17_-_34122596 | 1.53 |
ENST00000250144.8
|
MMP28
|
matrix metallopeptidase 28 |
| chr7_-_97501432 | 1.52 |
ENST00000394309.3
|
ASNS
|
asparagine synthetase (glutamine-hydrolyzing) |
| chr20_-_33880204 | 1.51 |
ENST00000374408.3
|
FAM83C
|
family with sequence similarity 83, member C |
| chrX_+_152086373 | 1.51 |
ENST00000318529.8
|
ZNF185
|
zinc finger protein 185 (LIM domain) |
| chr3_-_48130707 | 1.51 |
ENST00000360240.6
ENST00000383737.4 |
MAP4
|
microtubule-associated protein 4 |
| chr12_-_8814669 | 1.51 |
ENST00000535411.1
ENST00000540087.1 |
MFAP5
|
microfibrillar associated protein 5 |
| chrX_+_135229559 | 1.50 |
ENST00000394155.2
|
FHL1
|
four and a half LIM domains 1 |
| chr19_+_38810447 | 1.50 |
ENST00000263372.3
|
KCNK6
|
potassium channel, subfamily K, member 6 |
| chr8_+_124194875 | 1.49 |
ENST00000522648.1
ENST00000276699.6 |
FAM83A
|
family with sequence similarity 83, member A |
| chr2_-_96781984 | 1.49 |
ENST00000409345.3
|
ADRA2B
|
adrenoceptor alpha 2B |
| chr20_-_36793663 | 1.49 |
ENST00000536701.1
ENST00000536724.1 |
TGM2
|
transglutaminase 2 |
| chr8_+_124194752 | 1.49 |
ENST00000318462.6
|
FAM83A
|
family with sequence similarity 83, member A |
| chr16_+_88923494 | 1.48 |
ENST00000567895.1
ENST00000301021.3 ENST00000565504.1 ENST00000567312.1 ENST00000568583.1 ENST00000561840.1 |
TRAPPC2L
|
trafficking protein particle complex 2-like |
| chr12_+_57853918 | 1.48 |
ENST00000532291.1
ENST00000543426.1 ENST00000228682.2 ENST00000546141.1 |
GLI1
|
GLI family zinc finger 1 |
| chr11_-_568369 | 1.47 |
ENST00000534540.1
ENST00000528245.1 ENST00000500447.1 ENST00000533920.1 |
MIR210HG
|
MIR210 host gene (non-protein coding) |
| chr11_+_13690249 | 1.47 |
ENST00000532701.1
|
FAR1
|
fatty acyl CoA reductase 1 |
| chr20_-_50808236 | 1.47 |
ENST00000361387.2
|
ZFP64
|
ZFP64 zinc finger protein |
| chr6_-_109777128 | 1.47 |
ENST00000358807.3
ENST00000358577.3 |
MICAL1
|
microtubule associated monooxygenase, calponin and LIM domain containing 1 |
| chr20_+_43343517 | 1.46 |
ENST00000372865.4
|
WISP2
|
WNT1 inducible signaling pathway protein 2 |
| chr17_-_39928106 | 1.45 |
ENST00000540235.1
|
JUP
|
junction plakoglobin |
| chr1_+_1550795 | 1.45 |
ENST00000520777.1
ENST00000357210.4 ENST00000360522.4 ENST00000378710.3 ENST00000355826.5 ENST00000518681.1 ENST00000505820.2 |
MIB2
|
mindbomb E3 ubiquitin protein ligase 2 |
| chr6_-_53213587 | 1.44 |
ENST00000542638.1
ENST00000370913.5 ENST00000541407.1 |
ELOVL5
|
ELOVL fatty acid elongase 5 |
| chr16_+_725650 | 1.43 |
ENST00000352681.3
ENST00000561556.1 |
RHBDL1
|
rhomboid, veinlet-like 1 (Drosophila) |
| chr1_-_156542328 | 1.38 |
ENST00000361170.2
|
IQGAP3
|
IQ motif containing GTPase activating protein 3 |
| chr7_-_143059845 | 1.37 |
ENST00000443739.2
|
FAM131B
|
family with sequence similarity 131, member B |
| chr11_-_61646054 | 1.36 |
ENST00000527379.1
|
FADS3
|
fatty acid desaturase 3 |
| chr20_+_43343476 | 1.36 |
ENST00000372868.2
|
WISP2
|
WNT1 inducible signaling pathway protein 2 |
| chr11_-_73472096 | 1.36 |
ENST00000541588.1
ENST00000336083.3 ENST00000540771.1 ENST00000310653.6 |
RAB6A
|
RAB6A, member RAS oncogene family |
| chr2_+_127656486 | 1.35 |
ENST00000568484.1
ENST00000450035.1 |
AC114783.1
|
Protein LOC339760 |
| chr1_-_26232522 | 1.35 |
ENST00000399728.1
|
STMN1
|
stathmin 1 |
| chr14_+_75469606 | 1.34 |
ENST00000266126.5
|
EIF2B2
|
eukaryotic translation initiation factor 2B, subunit 2 beta, 39kDa |
| chr17_-_34808047 | 1.32 |
ENST00000592614.1
ENST00000591542.1 ENST00000330458.7 ENST00000341264.6 ENST00000592987.1 ENST00000400684.4 |
TBC1D3G
TBC1D3H
|
TBC1 domain family, member 3G TBC1 domain family, member 3H |
| chr3_-_179169330 | 1.31 |
ENST00000232564.3
|
GNB4
|
guanine nucleotide binding protein (G protein), beta polypeptide 4 |
| chr14_+_105155925 | 1.31 |
ENST00000330634.7
ENST00000398337.4 ENST00000392634.4 |
INF2
|
inverted formin, FH2 and WH2 domain containing |
| chr1_+_11994715 | 1.30 |
ENST00000449038.1
ENST00000376369.3 ENST00000429000.2 ENST00000196061.4 |
PLOD1
|
procollagen-lysine, 2-oxoglutarate 5-dioxygenase 1 |
| chrX_+_135618258 | 1.30 |
ENST00000440515.1
ENST00000456412.1 |
VGLL1
|
vestigial like 1 (Drosophila) |
| chr6_-_2876744 | 1.28 |
ENST00000420981.2
|
RP11-420G6.4
|
RP11-420G6.4 |
| chr5_-_132112921 | 1.28 |
ENST00000378721.4
ENST00000378701.1 |
SEPT8
|
septin 8 |
| chr17_-_7307358 | 1.27 |
ENST00000576017.1
ENST00000302422.3 ENST00000535512.1 |
TMEM256
TMEM256-PLSCR3
|
transmembrane protein 256 TMEM256-PLSCR3 readthrough (NMD candidate) |
| chr19_-_49015050 | 1.27 |
ENST00000600059.1
|
LMTK3
|
lemur tyrosine kinase 3 |
| chrX_-_152486108 | 1.27 |
ENST00000356661.5
|
MAGEA1
|
melanoma antigen family A, 1 (directs expression of antigen MZ2-E) |
| chr6_+_31371337 | 1.27 |
ENST00000449934.2
ENST00000421350.1 |
MICA
|
MHC class I polypeptide-related sequence A |
| chr14_+_106938440 | 1.27 |
ENST00000433371.1
ENST00000449670.1 ENST00000334298.3 |
LINC00221
|
long intergenic non-protein coding RNA 221 |
| chr1_+_35544968 | 1.26 |
ENST00000359858.4
ENST00000373330.1 |
ZMYM1
|
zinc finger, MYM-type 1 |
| chr1_+_155178518 | 1.26 |
ENST00000316721.4
|
MTX1
|
metaxin 1 |
| chr5_-_132112907 | 1.25 |
ENST00000458488.2
|
SEPT8
|
septin 8 |
| chr9_+_135937365 | 1.24 |
ENST00000372080.4
ENST00000351304.7 |
CEL
|
carboxyl ester lipase |
| chr16_+_70680439 | 1.24 |
ENST00000288098.2
|
IL34
|
interleukin 34 |
| chr19_+_36024310 | 1.23 |
ENST00000222286.4
|
GAPDHS
|
glyceraldehyde-3-phosphate dehydrogenase, spermatogenic |
| chr3_+_10068095 | 1.22 |
ENST00000287647.3
ENST00000383807.1 ENST00000383806.1 ENST00000419585.1 |
FANCD2
|
Fanconi anemia, complementation group D2 |
| chr13_-_24007815 | 1.22 |
ENST00000382298.3
|
SACS
|
spastic ataxia of Charlevoix-Saguenay (sacsin) |
| chr12_-_54779511 | 1.22 |
ENST00000551109.1
ENST00000546970.1 |
ZNF385A
|
zinc finger protein 385A |
| chr17_+_18647326 | 1.22 |
ENST00000395667.1
ENST00000395665.4 ENST00000308799.4 ENST00000301938.4 |
FBXW10
|
F-box and WD repeat domain containing 10 |
| chr6_+_34204642 | 1.21 |
ENST00000347617.6
ENST00000401473.3 ENST00000311487.5 ENST00000447654.1 ENST00000395004.3 |
HMGA1
|
high mobility group AT-hook 1 |
| chr9_-_131872928 | 1.21 |
ENST00000455830.2
ENST00000393384.3 ENST00000318080.2 |
CRAT
|
carnitine O-acetyltransferase |
| chrX_+_2984874 | 1.19 |
ENST00000359361.2
|
ARSF
|
arylsulfatase F |
| chr1_+_155178481 | 1.19 |
ENST00000368376.3
|
MTX1
|
metaxin 1 |
| chr10_-_116164450 | 1.19 |
ENST00000369271.3
|
AFAP1L2
|
actin filament associated protein 1-like 2 |
| chr17_-_39274606 | 1.18 |
ENST00000391413.2
|
KRTAP4-11
|
keratin associated protein 4-11 |
| chrX_-_153775426 | 1.17 |
ENST00000393562.2
|
G6PD
|
glucose-6-phosphate dehydrogenase |
| chr17_+_73750699 | 1.17 |
ENST00000584939.1
|
ITGB4
|
integrin, beta 4 |
| chr16_+_88704978 | 1.17 |
ENST00000244241.4
|
IL17C
|
interleukin 17C |
| chr17_+_17942594 | 1.17 |
ENST00000268719.4
|
GID4
|
GID complex subunit 4 |
| chr11_-_128457446 | 1.15 |
ENST00000392668.4
|
ETS1
|
v-ets avian erythroblastosis virus E26 oncogene homolog 1 |
| chr11_-_64085533 | 1.15 |
ENST00000544844.1
|
TRMT112
|
tRNA methyltransferase 11-2 homolog (S. cerevisiae) |
| chr17_-_38574169 | 1.15 |
ENST00000423485.1
|
TOP2A
|
topoisomerase (DNA) II alpha 170kDa |
| chr11_+_124735282 | 1.14 |
ENST00000397801.1
|
ROBO3
|
roundabout, axon guidance receptor, homolog 3 (Drosophila) |
| chr2_-_224702740 | 1.13 |
ENST00000444408.1
|
AP1S3
|
adaptor-related protein complex 1, sigma 3 subunit |
| chr10_+_75910960 | 1.13 |
ENST00000539909.1
ENST00000286621.2 |
ADK
|
adenosine kinase |
| chr9_+_126118449 | 1.13 |
ENST00000359999.3
ENST00000373631.3 |
CRB2
|
crumbs homolog 2 (Drosophila) |
Network of associatons between targets according to the STRING database.
First level regulatory network of GLI3
Gene Ontology Analysis
Gene overrepresentation in biological_process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 3.6 | 21.3 | GO:0002803 | positive regulation of antimicrobial peptide production(GO:0002225) positive regulation of antimicrobial humoral response(GO:0002760) positive regulation of antibacterial peptide production(GO:0002803) |
| 2.4 | 9.7 | GO:0010900 | negative regulation of phosphatidylcholine catabolic process(GO:0010900) |
| 1.9 | 5.7 | GO:0015920 | lipopolysaccharide transport(GO:0015920) |
| 1.5 | 4.5 | GO:0018262 | isopeptide cross-linking via N6-(L-isoglutamyl)-L-lysine(GO:0018153) isopeptide cross-linking(GO:0018262) |
| 1.2 | 4.6 | GO:0070981 | L-asparagine biosynthetic process(GO:0070981) L-asparagine metabolic process(GO:0070982) |
| 1.1 | 4.4 | GO:0003095 | pressure natriuresis(GO:0003095) |
| 1.0 | 5.2 | GO:0032487 | regulation of Rap protein signal transduction(GO:0032487) |
| 1.0 | 2.9 | GO:0060279 | regulation of ovulation(GO:0060278) positive regulation of ovulation(GO:0060279) |
| 0.9 | 4.4 | GO:0048817 | negative regulation of hair follicle maturation(GO:0048817) |
| 0.9 | 8.5 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
| 0.8 | 2.4 | GO:0046946 | hydroxylysine metabolic process(GO:0046946) hydroxylysine biosynthetic process(GO:0046947) |
| 0.8 | 2.3 | GO:0042270 | protection from natural killer cell mediated cytotoxicity(GO:0042270) |
| 0.8 | 2.3 | GO:0044209 | AMP salvage(GO:0044209) |
| 0.7 | 3.0 | GO:0002545 | chronic inflammatory response to non-antigenic stimulus(GO:0002545) regulation of chronic inflammatory response to non-antigenic stimulus(GO:0002880) |
| 0.7 | 2.8 | GO:1904565 | response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904565) cellular response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904566) |
| 0.7 | 3.4 | GO:1905098 | negative regulation of guanyl-nucleotide exchange factor activity(GO:1905098) |
| 0.6 | 6.8 | GO:0010820 | positive regulation of T cell chemotaxis(GO:0010820) |
| 0.6 | 8.5 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
| 0.6 | 1.8 | GO:1903570 | regulation of protein kinase D signaling(GO:1903570) positive regulation of protein kinase D signaling(GO:1903572) |
| 0.6 | 3.5 | GO:0090131 | mesenchyme migration(GO:0090131) |
| 0.6 | 4.6 | GO:0050689 | negative regulation of defense response to virus by host(GO:0050689) |
| 0.6 | 3.4 | GO:0038172 | interleukin-33-mediated signaling pathway(GO:0038172) |
| 0.5 | 1.1 | GO:0002581 | negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002581) |
| 0.5 | 1.6 | GO:0014806 | negative regulation of muscle hyperplasia(GO:0014740) smooth muscle hyperplasia(GO:0014806) |
| 0.5 | 2.7 | GO:0061767 | negative regulation of lung blood pressure(GO:0061767) |
| 0.5 | 4.8 | GO:0019368 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
| 0.5 | 1.6 | GO:0000412 | histone peptidyl-prolyl isomerization(GO:0000412) |
| 0.5 | 2.6 | GO:0008611 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) ether biosynthetic process(GO:1901503) |
| 0.5 | 4.6 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
| 0.5 | 1.5 | GO:0035625 | epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway(GO:0035625) |
| 0.5 | 3.0 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
| 0.5 | 1.5 | GO:0019417 | sulfur oxidation(GO:0019417) |
| 0.5 | 1.4 | GO:0045014 | carbon catabolite repression of transcription(GO:0045013) negative regulation of transcription by glucose(GO:0045014) |
| 0.4 | 12.8 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
| 0.4 | 2.1 | GO:0010609 | mRNA localization resulting in posttranscriptional regulation of gene expression(GO:0010609) regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902162) positive regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902164) |
| 0.4 | 1.2 | GO:0019254 | carnitine metabolic process, CoA-linked(GO:0019254) |
| 0.4 | 1.2 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
| 0.4 | 4.3 | GO:0007144 | female meiosis I(GO:0007144) |
| 0.4 | 1.9 | GO:0061146 | Peyer's patch morphogenesis(GO:0061146) |
| 0.4 | 1.5 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
| 0.4 | 1.9 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
| 0.4 | 1.9 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
| 0.4 | 0.7 | GO:0006788 | heme oxidation(GO:0006788) |
| 0.4 | 2.6 | GO:0021842 | directional guidance of interneurons involved in migration from the subpallium to the cortex(GO:0021840) chemorepulsion involved in interneuron migration from the subpallium to the cortex(GO:0021842) |
| 0.4 | 2.2 | GO:0015808 | L-alanine transport(GO:0015808) L-cystine transport(GO:0015811) |
| 0.4 | 1.8 | GO:0044208 | 'de novo' AMP biosynthetic process(GO:0044208) |
| 0.4 | 1.1 | GO:0098838 | reduced folate transmembrane transport(GO:0098838) |
| 0.4 | 1.1 | GO:1903249 | regulation of cellular amine catabolic process(GO:0033241) negative regulation of cellular amine catabolic process(GO:0033242) negative regulation of the force of heart contraction(GO:0098736) regulation of arginine catabolic process(GO:1900081) negative regulation of arginine catabolic process(GO:1900082) regulation of citrulline biosynthetic process(GO:1903248) negative regulation of citrulline biosynthetic process(GO:1903249) negative regulation of cellular amino acid biosynthetic process(GO:2000283) |
| 0.3 | 1.7 | GO:0071603 | endothelial cell-cell adhesion(GO:0071603) |
| 0.3 | 1.7 | GO:0045337 | geranyl diphosphate metabolic process(GO:0033383) geranyl diphosphate biosynthetic process(GO:0033384) farnesyl diphosphate biosynthetic process(GO:0045337) |
| 0.3 | 2.0 | GO:1903575 | cornified envelope assembly(GO:1903575) |
| 0.3 | 1.6 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
| 0.3 | 1.6 | GO:0046340 | diacylglycerol catabolic process(GO:0046340) |
| 0.3 | 1.0 | GO:0030264 | nuclear fragmentation involved in apoptotic nuclear change(GO:0030264) |
| 0.3 | 1.6 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
| 0.3 | 1.5 | GO:1901490 | regulation of lymphangiogenesis(GO:1901490) |
| 0.3 | 1.8 | GO:0071163 | DNA replication preinitiation complex assembly(GO:0071163) |
| 0.3 | 0.6 | GO:0051710 | regulation of cytolysis in other organism(GO:0051710) |
| 0.3 | 1.5 | GO:0010760 | negative regulation of macrophage chemotaxis(GO:0010760) |
| 0.3 | 0.9 | GO:0060084 | synaptic transmission involved in micturition(GO:0060084) |
| 0.3 | 0.9 | GO:0080154 | regulation of fertilization(GO:0080154) |
| 0.3 | 1.5 | GO:0007418 | ventral midline development(GO:0007418) smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation(GO:0021938) |
| 0.3 | 1.5 | GO:0044240 | multicellular organism lipid catabolic process(GO:0044240) |
| 0.3 | 0.9 | GO:0090187 | positive regulation of pancreatic juice secretion(GO:0090187) |
| 0.3 | 1.2 | GO:0085032 | modulation of signal transduction in other organism(GO:0044501) modulation by symbiont of host signal transduction pathway(GO:0052027) modulation of signal transduction in other organism involved in symbiotic interaction(GO:0052250) modulation by symbiont of host I-kappaB kinase/NF-kappaB cascade(GO:0085032) |
| 0.3 | 0.9 | GO:1904344 | positive regulation of growth rate(GO:0040010) regulation of gastric mucosal blood circulation(GO:1904344) positive regulation of gastric mucosal blood circulation(GO:1904346) gastric mucosal blood circulation(GO:1990768) |
| 0.3 | 1.7 | GO:0007296 | vitellogenesis(GO:0007296) |
| 0.3 | 3.1 | GO:0061042 | vascular wound healing(GO:0061042) |
| 0.3 | 0.8 | GO:0006423 | cysteinyl-tRNA aminoacylation(GO:0006423) |
| 0.3 | 1.1 | GO:0072344 | rescue of stalled ribosome(GO:0072344) |
| 0.3 | 2.7 | GO:0032926 | negative regulation of activin receptor signaling pathway(GO:0032926) |
| 0.3 | 0.8 | GO:0021849 | neuroblast division in subventricular zone(GO:0021849) |
| 0.3 | 12.8 | GO:0014046 | dopamine secretion(GO:0014046) regulation of dopamine secretion(GO:0014059) |
| 0.3 | 1.3 | GO:0038155 | interleukin-23-mediated signaling pathway(GO:0038155) |
| 0.3 | 1.8 | GO:1904526 | regulation of microtubule binding(GO:1904526) |
| 0.3 | 1.5 | GO:0051012 | microtubule sliding(GO:0051012) |
| 0.2 | 1.2 | GO:0014028 | notochord formation(GO:0014028) |
| 0.2 | 0.2 | GO:1903903 | regulation of establishment of T cell polarity(GO:1903903) |
| 0.2 | 1.2 | GO:0090402 | oncogene-induced cell senescence(GO:0090402) |
| 0.2 | 2.6 | GO:0015939 | pantothenate metabolic process(GO:0015939) |
| 0.2 | 0.7 | GO:0060370 | susceptibility to T cell mediated cytotoxicity(GO:0060370) |
| 0.2 | 5.2 | GO:0016540 | protein autoprocessing(GO:0016540) |
| 0.2 | 0.9 | GO:0044752 | response to human chorionic gonadotropin(GO:0044752) |
| 0.2 | 1.6 | GO:0033600 | negative regulation of mammary gland epithelial cell proliferation(GO:0033600) |
| 0.2 | 0.7 | GO:0016999 | antibiotic metabolic process(GO:0016999) |
| 0.2 | 1.6 | GO:0097240 | meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
| 0.2 | 1.8 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
| 0.2 | 1.1 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
| 0.2 | 0.9 | GO:0071393 | cellular response to progesterone stimulus(GO:0071393) |
| 0.2 | 0.6 | GO:0042938 | dipeptide transport(GO:0042938) |
| 0.2 | 1.1 | GO:0070829 | response to vitamin B2(GO:0033274) heterochromatin maintenance(GO:0070829) |
| 0.2 | 0.6 | GO:1902534 | single-organism membrane invagination(GO:1902534) |
| 0.2 | 0.8 | GO:0071484 | response to high light intensity(GO:0009644) cellular response to light intensity(GO:0071484) |
| 0.2 | 1.9 | GO:0015705 | iodide transport(GO:0015705) |
| 0.2 | 0.6 | GO:0002352 | B cell negative selection(GO:0002352) post-embryonic camera-type eye morphogenesis(GO:0048597) |
| 0.2 | 1.2 | GO:2000348 | regulation of CD40 signaling pathway(GO:2000348) |
| 0.2 | 1.6 | GO:0030578 | PML body organization(GO:0030578) |
| 0.2 | 0.6 | GO:0045226 | extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) |
| 0.2 | 0.8 | GO:1990262 | regulation of anti-Mullerian hormone signaling pathway(GO:1902612) negative regulation of anti-Mullerian hormone signaling pathway(GO:1902613) anti-Mullerian hormone signaling pathway(GO:1990262) |
| 0.2 | 0.8 | GO:0033512 | L-lysine catabolic process to acetyl-CoA via saccharopine(GO:0033512) |
| 0.2 | 0.4 | GO:0009310 | amine catabolic process(GO:0009310) |
| 0.2 | 0.7 | GO:0000430 | regulation of transcription from RNA polymerase II promoter by glucose(GO:0000430) positive regulation of transcription from RNA polymerase II promoter by glucose(GO:0000432) |
| 0.2 | 0.6 | GO:0086100 | endothelin receptor signaling pathway(GO:0086100) |
| 0.2 | 3.5 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
| 0.2 | 3.7 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
| 0.2 | 0.5 | GO:2000979 | hepatocyte cell migration(GO:0002194) otic placode formation(GO:0043049) branching involved in pancreas morphogenesis(GO:0061114) acinar cell differentiation(GO:0090425) positive regulation of forebrain neuron differentiation(GO:2000979) |
| 0.2 | 0.5 | GO:1990022 | RNA polymerase II complex import to nucleus(GO:0044376) RNA polymerase III complex localization to nucleus(GO:1990022) |
| 0.2 | 0.9 | GO:0043553 | vascular endothelial growth factor receptor-2 signaling pathway(GO:0036324) negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
| 0.2 | 1.6 | GO:0060020 | Bergmann glial cell differentiation(GO:0060020) |
| 0.2 | 4.5 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
| 0.2 | 0.3 | GO:0010644 | cell communication by electrical coupling(GO:0010644) |
| 0.2 | 1.9 | GO:0048672 | positive regulation of collateral sprouting(GO:0048672) |
| 0.2 | 0.7 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
| 0.2 | 4.2 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
| 0.2 | 0.5 | GO:0009449 | gamma-aminobutyric acid biosynthetic process(GO:0009449) |
| 0.2 | 0.8 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
| 0.2 | 1.1 | GO:0016199 | axon midline choice point recognition(GO:0016199) |
| 0.2 | 3.1 | GO:0030949 | positive regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030949) |
| 0.2 | 0.8 | GO:0071802 | negative regulation of podosome assembly(GO:0071802) |
| 0.2 | 0.5 | GO:0030451 | regulation of complement activation, alternative pathway(GO:0030451) negative regulation of complement activation, alternative pathway(GO:0045957) |
| 0.2 | 1.1 | GO:2001137 | positive regulation of endocytic recycling(GO:2001137) |
| 0.2 | 0.5 | GO:0019285 | glycine betaine biosynthetic process from choline(GO:0019285) glycine betaine metabolic process(GO:0031455) glycine betaine biosynthetic process(GO:0031456) |
| 0.2 | 0.6 | GO:0016103 | diterpenoid catabolic process(GO:0016103) retinoic acid catabolic process(GO:0034653) |
| 0.2 | 0.8 | GO:0002826 | negative regulation of T-helper 1 type immune response(GO:0002826) negative regulation of T-helper 1 cell differentiation(GO:0045626) response to odorant(GO:1990834) |
| 0.2 | 3.3 | GO:0090110 | cargo loading into COPII-coated vesicle(GO:0090110) |
| 0.2 | 1.4 | GO:0070315 | G1 to G0 transition involved in cell differentiation(GO:0070315) |
| 0.2 | 0.6 | GO:0006238 | CMP salvage(GO:0006238) CMP biosynthetic process(GO:0009224) CMP metabolic process(GO:0046035) |
| 0.2 | 0.6 | GO:0034441 | plasma lipoprotein particle oxidation(GO:0034441) |
| 0.2 | 0.6 | GO:0050653 | chondroitin sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0050653) |
| 0.1 | 4.2 | GO:0001829 | trophectodermal cell differentiation(GO:0001829) |
| 0.1 | 0.6 | GO:0022007 | neural plate elongation(GO:0014022) convergent extension involved in neural plate elongation(GO:0022007) |
| 0.1 | 0.7 | GO:2000255 | negative regulation of male germ cell proliferation(GO:2000255) |
| 0.1 | 0.9 | GO:0030421 | defecation(GO:0030421) |
| 0.1 | 1.4 | GO:0008360 | regulation of cell shape(GO:0008360) |
| 0.1 | 1.8 | GO:0038007 | netrin-activated signaling pathway(GO:0038007) |
| 0.1 | 1.0 | GO:0001957 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
| 0.1 | 0.4 | GO:0002522 | leukocyte migration involved in immune response(GO:0002522) |
| 0.1 | 1.0 | GO:0071763 | nuclear membrane organization(GO:0071763) |
| 0.1 | 3.4 | GO:0033540 | fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540) |
| 0.1 | 2.4 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
| 0.1 | 0.4 | GO:0031630 | regulation of synaptic vesicle fusion to presynaptic membrane(GO:0031630) |
| 0.1 | 0.7 | GO:0071442 | positive regulation of histone H3-K14 acetylation(GO:0071442) |
| 0.1 | 0.4 | GO:0019853 | L-ascorbic acid biosynthetic process(GO:0019853) positive regulation of calcium-transporting ATPase activity(GO:1901896) negative regulation of DNA catabolic process(GO:1903625) regulation of aminoacyl-tRNA ligase activity(GO:1903630) |
| 0.1 | 0.9 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
| 0.1 | 1.4 | GO:0071394 | cellular response to testosterone stimulus(GO:0071394) |
| 0.1 | 0.5 | GO:1903527 | positive regulation of membrane tubulation(GO:1903527) protein localization to vacuolar membrane(GO:1903778) |
| 0.1 | 0.8 | GO:0038031 | non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
| 0.1 | 0.4 | GO:1902310 | positive regulation of peptidyl-serine dephosphorylation(GO:1902310) |
| 0.1 | 0.6 | GO:0036506 | maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
| 0.1 | 0.4 | GO:0060612 | adipose tissue development(GO:0060612) |
| 0.1 | 0.1 | GO:0008228 | opsonization(GO:0008228) |
| 0.1 | 2.0 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
| 0.1 | 0.8 | GO:0044800 | fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
| 0.1 | 0.4 | GO:0017186 | peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase(GO:0017186) |
| 0.1 | 0.3 | GO:0030901 | substantia nigra development(GO:0021762) midbrain development(GO:0030901) neural nucleus development(GO:0048857) |
| 0.1 | 1.1 | GO:0040016 | embryonic cleavage(GO:0040016) |
| 0.1 | 0.2 | GO:1903898 | negative regulation of PERK-mediated unfolded protein response(GO:1903898) negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation(GO:1903912) |
| 0.1 | 1.6 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
| 0.1 | 0.8 | GO:0003383 | apical constriction(GO:0003383) |
| 0.1 | 0.2 | GO:0051464 | cortisol secretion(GO:0043400) regulation of cortisol secretion(GO:0051462) positive regulation of cortisol secretion(GO:0051464) |
| 0.1 | 0.2 | GO:0071681 | response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
| 0.1 | 2.9 | GO:0007398 | ectoderm development(GO:0007398) |
| 0.1 | 1.0 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
| 0.1 | 1.2 | GO:0097398 | response to interleukin-17(GO:0097396) cellular response to interleukin-17(GO:0097398) |
| 0.1 | 2.1 | GO:1903204 | negative regulation of oxidative stress-induced neuron death(GO:1903204) |
| 0.1 | 0.8 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
| 0.1 | 0.7 | GO:0007386 | compartment pattern specification(GO:0007386) |
| 0.1 | 0.7 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
| 0.1 | 1.3 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
| 0.1 | 2.1 | GO:0034587 | piRNA metabolic process(GO:0034587) |
| 0.1 | 0.4 | GO:2000630 | positive regulation of miRNA metabolic process(GO:2000630) |
| 0.1 | 0.4 | GO:0045356 | positive regulation of interferon-alpha biosynthetic process(GO:0045356) |
| 0.1 | 0.5 | GO:0002857 | positive regulation of natural killer cell mediated immune response to tumor cell(GO:0002857) positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002860) |
| 0.1 | 1.5 | GO:0003085 | negative regulation of systemic arterial blood pressure(GO:0003085) |
| 0.1 | 1.4 | GO:0033601 | positive regulation of mammary gland epithelial cell proliferation(GO:0033601) |
| 0.1 | 0.7 | GO:0042760 | very long-chain fatty acid catabolic process(GO:0042760) |
| 0.1 | 0.6 | GO:0007028 | cytoplasm organization(GO:0007028) |
| 0.1 | 0.2 | GO:1900220 | semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis(GO:1900220) |
| 0.1 | 1.2 | GO:2000347 | positive regulation of hepatocyte proliferation(GO:2000347) |
| 0.1 | 0.3 | GO:1901382 | chorionic trophoblast cell proliferation(GO:0097360) regulation of chorionic trophoblast cell proliferation(GO:1901382) |
| 0.1 | 1.5 | GO:0000338 | protein deneddylation(GO:0000338) |
| 0.1 | 0.6 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
| 0.1 | 0.5 | GO:0019747 | regulation of isoprenoid metabolic process(GO:0019747) |
| 0.1 | 0.4 | GO:0035617 | stress granule disassembly(GO:0035617) |
| 0.1 | 0.7 | GO:1903764 | regulation of potassium ion export across plasma membrane(GO:1903764) |
| 0.1 | 2.2 | GO:0009263 | deoxyribonucleotide biosynthetic process(GO:0009263) |
| 0.1 | 0.4 | GO:0000711 | meiotic DNA repair synthesis(GO:0000711) |
| 0.1 | 0.3 | GO:0035672 | oligopeptide transmembrane transport(GO:0035672) |
| 0.1 | 0.4 | GO:0038195 | urokinase plasminogen activator signaling pathway(GO:0038195) |
| 0.1 | 0.7 | GO:0046087 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
| 0.1 | 0.3 | GO:0043311 | regulation of eosinophil degranulation(GO:0043309) positive regulation of eosinophil degranulation(GO:0043311) positive regulation of eosinophil activation(GO:1902568) |
| 0.1 | 0.3 | GO:0015911 | plasma membrane long-chain fatty acid transport(GO:0015911) |
| 0.1 | 2.1 | GO:0035589 | G-protein coupled purinergic nucleotide receptor signaling pathway(GO:0035589) |
| 0.1 | 0.4 | GO:2001268 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001268) |
| 0.1 | 0.4 | GO:0060613 | fat pad development(GO:0060613) |
| 0.1 | 1.0 | GO:1900864 | mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
| 0.1 | 0.9 | GO:0019344 | cysteine biosynthetic process(GO:0019344) |
| 0.1 | 11.8 | GO:0006939 | smooth muscle contraction(GO:0006939) |
| 0.1 | 0.3 | GO:0045918 | negative regulation of cytolysis(GO:0045918) |
| 0.1 | 5.4 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
| 0.1 | 0.2 | GO:0003162 | atrioventricular node development(GO:0003162) |
| 0.1 | 0.6 | GO:1900264 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
| 0.1 | 0.3 | GO:0072719 | positive regulation of endodeoxyribonuclease activity(GO:0032079) cellular response to cisplatin(GO:0072719) |
| 0.1 | 0.6 | GO:0090037 | positive regulation of protein kinase C signaling(GO:0090037) |
| 0.1 | 0.7 | GO:0009826 | unidimensional cell growth(GO:0009826) |
| 0.1 | 0.8 | GO:0061077 | chaperone-mediated protein folding(GO:0061077) |
| 0.1 | 0.2 | GO:1903697 | negative regulation of microvillus assembly(GO:1903697) |
| 0.1 | 0.4 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
| 0.1 | 4.0 | GO:0050690 | regulation of defense response to virus by virus(GO:0050690) |
| 0.1 | 0.4 | GO:0048102 | autophagic cell death(GO:0048102) |
| 0.1 | 1.4 | GO:0007021 | tubulin complex assembly(GO:0007021) |
| 0.1 | 0.5 | GO:0045163 | clustering of voltage-gated potassium channels(GO:0045163) |
| 0.1 | 0.2 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
| 0.1 | 1.4 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
| 0.1 | 0.9 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
| 0.1 | 0.5 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
| 0.1 | 0.5 | GO:1904627 | response to phorbol 13-acetate 12-myristate(GO:1904627) cellular response to phorbol 13-acetate 12-myristate(GO:1904628) |
| 0.1 | 0.2 | GO:0002317 | plasma cell differentiation(GO:0002317) |
| 0.1 | 0.2 | GO:0060374 | positive regulation of chromatin assembly or disassembly(GO:0045799) mast cell differentiation(GO:0060374) |
| 0.1 | 0.4 | GO:0071051 | polyadenylation-dependent snoRNA 3'-end processing(GO:0071051) |
| 0.1 | 0.2 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
| 0.1 | 0.3 | GO:2000568 | memory T cell activation(GO:0035709) regulation of memory T cell activation(GO:2000567) positive regulation of memory T cell activation(GO:2000568) |
| 0.1 | 0.2 | GO:1904580 | regulation of intracellular mRNA localization(GO:1904580) positive regulation of intracellular mRNA localization(GO:1904582) |
| 0.1 | 1.0 | GO:0007172 | signal complex assembly(GO:0007172) |
| 0.1 | 0.6 | GO:0045905 | translational frameshifting(GO:0006452) positive regulation of translational termination(GO:0045905) |
| 0.1 | 0.7 | GO:0048733 | sebaceous gland development(GO:0048733) |
| 0.1 | 0.4 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
| 0.1 | 5.8 | GO:0060113 | inner ear receptor cell differentiation(GO:0060113) |
| 0.1 | 0.9 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
| 0.1 | 0.3 | GO:0043375 | cochlear nucleus development(GO:0021747) negative regulation of cellular pH reduction(GO:0032848) CD8-positive, alpha-beta T cell lineage commitment(GO:0043375) negative regulation of retinal cell programmed cell death(GO:0046671) |
| 0.1 | 0.3 | GO:0051340 | regulation of ligase activity(GO:0051340) positive regulation of ligase activity(GO:0051351) positive regulation of ubiquitin-protein transferase activity(GO:0051443) |
| 0.1 | 1.2 | GO:0045651 | positive regulation of macrophage differentiation(GO:0045651) |
| 0.1 | 0.3 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
| 0.1 | 0.3 | GO:2001191 | gamma-delta T cell activation involved in immune response(GO:0002290) negative regulation of interferon-beta secretion(GO:0035548) regulation of gamma-delta T cell activation involved in immune response(GO:2001191) positive regulation of gamma-delta T cell activation involved in immune response(GO:2001193) |
| 0.1 | 1.2 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
| 0.1 | 0.6 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
| 0.1 | 1.1 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
| 0.1 | 2.6 | GO:0034446 | substrate adhesion-dependent cell spreading(GO:0034446) |
| 0.1 | 0.4 | GO:0007619 | courtship behavior(GO:0007619) |
| 0.1 | 2.4 | GO:0032757 | positive regulation of interleukin-8 production(GO:0032757) |
| 0.1 | 8.0 | GO:0090630 | activation of GTPase activity(GO:0090630) |
| 0.1 | 0.5 | GO:0001865 | NK T cell differentiation(GO:0001865) |
| 0.1 | 0.4 | GO:0043461 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
| 0.1 | 0.5 | GO:0000480 | endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000480) |
| 0.1 | 0.5 | GO:0015755 | fructose transport(GO:0015755) fructose import(GO:0032445) carbohydrate import into cell(GO:0097319) carbohydrate import across plasma membrane(GO:0098704) fructose import across plasma membrane(GO:1990539) |
| 0.1 | 0.9 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
| 0.1 | 0.4 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
| 0.1 | 0.2 | GO:0042700 | luteinizing hormone signaling pathway(GO:0042700) |
| 0.1 | 0.3 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
| 0.1 | 0.3 | GO:0000720 | pyrimidine dimer repair by nucleotide-excision repair(GO:0000720) |
| 0.1 | 0.5 | GO:0048549 | positive regulation of pinocytosis(GO:0048549) |
| 0.1 | 0.8 | GO:0016322 | neuron remodeling(GO:0016322) |
| 0.1 | 0.4 | GO:0070777 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
| 0.1 | 0.2 | GO:0003094 | glomerular filtration(GO:0003094) renal filtration(GO:0097205) |
| 0.1 | 4.4 | GO:0018149 | peptide cross-linking(GO:0018149) |
| 0.1 | 0.4 | GO:0071926 | endocannabinoid signaling pathway(GO:0071926) regulation of endocannabinoid signaling pathway(GO:2000124) |
| 0.1 | 0.3 | GO:0072674 | multinuclear osteoclast differentiation(GO:0072674) osteoclast fusion(GO:0072675) |
| 0.1 | 1.1 | GO:0006875 | cellular metal ion homeostasis(GO:0006875) |
| 0.1 | 0.3 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
| 0.1 | 1.7 | GO:0051649 | establishment of localization in cell(GO:0051649) |
| 0.1 | 1.6 | GO:0046475 | glycerophospholipid catabolic process(GO:0046475) |
| 0.1 | 1.1 | GO:2001197 | regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904259) positive regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904261) basement membrane assembly involved in embryonic body morphogenesis(GO:2001197) |
| 0.1 | 0.6 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
| 0.1 | 0.3 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
| 0.1 | 0.6 | GO:0043031 | negative regulation of macrophage activation(GO:0043031) |
| 0.1 | 0.5 | GO:0042325 | regulation of phosphorylation(GO:0042325) |
| 0.1 | 2.6 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
| 0.1 | 1.6 | GO:0043011 | myeloid dendritic cell differentiation(GO:0043011) |
| 0.1 | 0.5 | GO:0007256 | activation of JNKK activity(GO:0007256) |
| 0.1 | 0.2 | GO:0006049 | UDP-N-acetylglucosamine catabolic process(GO:0006049) |
| 0.1 | 0.3 | GO:0046498 | S-adenosylhomocysteine metabolic process(GO:0046498) |
| 0.1 | 0.3 | GO:0060754 | positive regulation of mast cell chemotaxis(GO:0060754) |
| 0.1 | 0.7 | GO:0060716 | labyrinthine layer blood vessel development(GO:0060716) |
| 0.1 | 0.6 | GO:0007135 | meiosis II(GO:0007135) |
| 0.1 | 0.1 | GO:1990418 | response to insulin-like growth factor stimulus(GO:1990418) |
| 0.1 | 0.3 | GO:0061756 | leukocyte tethering or rolling(GO:0050901) leukocyte adhesion to vascular endothelial cell(GO:0061756) |
| 0.1 | 0.1 | GO:0042636 | negative regulation of hair cycle(GO:0042636) |
| 0.1 | 1.0 | GO:0044342 | type B pancreatic cell proliferation(GO:0044342) |
| 0.1 | 0.3 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
| 0.1 | 0.3 | GO:0022417 | protein maturation by protein folding(GO:0022417) |
| 0.1 | 0.5 | GO:0035459 | cargo loading into vesicle(GO:0035459) |
| 0.1 | 0.1 | GO:0042701 | progesterone secretion(GO:0042701) |
| 0.1 | 1.3 | GO:0090140 | regulation of mitochondrial fission(GO:0090140) |
| 0.1 | 0.3 | GO:0000023 | maltose metabolic process(GO:0000023) |
| 0.1 | 0.2 | GO:1905205 | positive regulation of connective tissue replacement(GO:1905205) |
| 0.1 | 0.3 | GO:0006021 | inositol biosynthetic process(GO:0006021) |
| 0.1 | 0.4 | GO:0038110 | interleukin-2-mediated signaling pathway(GO:0038110) |
| 0.0 | 0.2 | GO:0070980 | biphenyl catabolic process(GO:0070980) |
| 0.0 | 0.1 | GO:0070431 | nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070431) |
| 0.0 | 0.4 | GO:0061299 | retina vasculature morphogenesis in camera-type eye(GO:0061299) |
| 0.0 | 2.0 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
| 0.0 | 0.6 | GO:0034454 | microtubule anchoring at centrosome(GO:0034454) |
| 0.0 | 0.4 | GO:0030968 | endoplasmic reticulum unfolded protein response(GO:0030968) |
| 0.0 | 1.7 | GO:0007019 | microtubule depolymerization(GO:0007019) |
| 0.0 | 0.2 | GO:2000609 | regulation of thyroid hormone generation(GO:2000609) |
| 0.0 | 0.9 | GO:0046415 | urate metabolic process(GO:0046415) |
| 0.0 | 0.1 | GO:0046416 | D-amino acid metabolic process(GO:0046416) |
| 0.0 | 1.1 | GO:0044030 | regulation of DNA methylation(GO:0044030) |
| 0.0 | 0.3 | GO:0090042 | tubulin deacetylation(GO:0090042) regulation of tubulin deacetylation(GO:0090043) |
| 0.0 | 0.1 | GO:0046166 | glyceraldehyde-3-phosphate biosynthetic process(GO:0046166) |
| 0.0 | 0.3 | GO:0006402 | mRNA catabolic process(GO:0006402) |
| 0.0 | 0.4 | GO:0019896 | axonal transport of mitochondrion(GO:0019896) |
| 0.0 | 0.2 | GO:0045903 | positive regulation of translational fidelity(GO:0045903) |
| 0.0 | 0.3 | GO:0060125 | negative regulation of growth hormone secretion(GO:0060125) |
| 0.0 | 1.2 | GO:0061003 | positive regulation of dendritic spine morphogenesis(GO:0061003) |
| 0.0 | 0.5 | GO:0002028 | regulation of sodium ion transport(GO:0002028) |
| 0.0 | 0.1 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
| 0.0 | 0.8 | GO:0045618 | positive regulation of keratinocyte differentiation(GO:0045618) |
| 0.0 | 0.5 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
| 0.0 | 0.4 | GO:0070673 | response to interleukin-18(GO:0070673) |
| 0.0 | 0.6 | GO:0038003 | opioid receptor signaling pathway(GO:0038003) |
| 0.0 | 0.5 | GO:1902570 | protein localization to nucleolus(GO:1902570) |
| 0.0 | 0.7 | GO:0001556 | oocyte maturation(GO:0001556) |
| 0.0 | 0.4 | GO:0051703 | social behavior(GO:0035176) intraspecies interaction between organisms(GO:0051703) |
| 0.0 | 0.4 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
| 0.0 | 0.3 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
| 0.0 | 4.8 | GO:0043154 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic process(GO:0043154) |
| 0.0 | 1.6 | GO:0045737 | positive regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045737) |
| 0.0 | 0.5 | GO:0060346 | bone trabecula formation(GO:0060346) bone trabecula morphogenesis(GO:0061430) |
| 0.0 | 0.2 | GO:0051490 | negative regulation of filopodium assembly(GO:0051490) |
| 0.0 | 1.5 | GO:0034260 | negative regulation of GTPase activity(GO:0034260) |
| 0.0 | 1.4 | GO:0097435 | fibril organization(GO:0097435) |
| 0.0 | 0.9 | GO:0000185 | activation of MAPKKK activity(GO:0000185) regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
| 0.0 | 0.6 | GO:0060856 | establishment of blood-brain barrier(GO:0060856) |
| 0.0 | 0.2 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
| 0.0 | 1.0 | GO:0045821 | positive regulation of glycolytic process(GO:0045821) positive regulation of cofactor metabolic process(GO:0051194) positive regulation of coenzyme metabolic process(GO:0051197) |
| 0.0 | 0.3 | GO:0014067 | negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) negative regulation of macromitophagy(GO:1901525) |
| 0.0 | 1.0 | GO:0035729 | cellular response to hepatocyte growth factor stimulus(GO:0035729) |
| 0.0 | 0.8 | GO:0042359 | vitamin D metabolic process(GO:0042359) |
| 0.0 | 0.6 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
| 0.0 | 0.2 | GO:0042711 | maternal behavior(GO:0042711) parental behavior(GO:0060746) |
| 0.0 | 0.6 | GO:0051256 | mitotic spindle midzone assembly(GO:0051256) |
| 0.0 | 0.3 | GO:0014850 | response to muscle activity(GO:0014850) |
| 0.0 | 0.9 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
| 0.0 | 0.8 | GO:0051560 | mitochondrial calcium ion homeostasis(GO:0051560) |
| 0.0 | 0.7 | GO:0006265 | DNA topological change(GO:0006265) |
| 0.0 | 1.6 | GO:0006509 | membrane protein ectodomain proteolysis(GO:0006509) |
| 0.0 | 0.2 | GO:0090494 | dopamine uptake involved in synaptic transmission(GO:0051583) catecholamine uptake involved in synaptic transmission(GO:0051934) catecholamine uptake(GO:0090493) dopamine uptake(GO:0090494) |
| 0.0 | 0.9 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
| 0.0 | 1.3 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
| 0.0 | 0.3 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
| 0.0 | 0.1 | GO:2000312 | regulation of kainate selective glutamate receptor activity(GO:2000312) |
| 0.0 | 1.6 | GO:0006376 | mRNA splice site selection(GO:0006376) |
| 0.0 | 0.1 | GO:1903597 | negative regulation of gap junction assembly(GO:1903597) |
| 0.0 | 0.3 | GO:0010603 | regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
| 0.0 | 2.0 | GO:0071377 | cellular response to glucagon stimulus(GO:0071377) |
| 0.0 | 0.6 | GO:1902001 | carnitine shuttle(GO:0006853) fatty acid transmembrane transport(GO:1902001) |
| 0.0 | 0.1 | GO:0061356 | Wnt protein secretion(GO:0061355) regulation of Wnt protein secretion(GO:0061356) positive regulation of Wnt protein secretion(GO:0061357) |
| 0.0 | 0.4 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
| 0.0 | 1.2 | GO:0045104 | intermediate filament cytoskeleton organization(GO:0045104) |
| 0.0 | 0.1 | GO:0090119 | vesicle-mediated cholesterol transport(GO:0090119) |
| 0.0 | 0.5 | GO:2000786 | positive regulation of autophagosome assembly(GO:2000786) |
| 0.0 | 1.1 | GO:0046825 | regulation of protein export from nucleus(GO:0046825) |
| 0.0 | 0.1 | GO:2000074 | regulation of type B pancreatic cell development(GO:2000074) |
| 0.0 | 0.5 | GO:0035090 | maintenance of apical/basal cell polarity(GO:0035090) maintenance of epithelial cell apical/basal polarity(GO:0045199) |
| 0.0 | 0.1 | GO:1904616 | regulation of actin filament binding(GO:1904529) negative regulation of actin filament binding(GO:1904530) regulation of actin binding(GO:1904616) negative regulation of actin binding(GO:1904617) |
| 0.0 | 0.4 | GO:0071800 | podosome assembly(GO:0071800) |
| 0.0 | 0.2 | GO:0055092 | cholesterol homeostasis(GO:0042632) sterol homeostasis(GO:0055092) |
| 0.0 | 2.3 | GO:0042471 | ear morphogenesis(GO:0042471) |
| 0.0 | 2.8 | GO:0007498 | mesoderm development(GO:0007498) |
| 0.0 | 0.8 | GO:0022038 | corpus callosum development(GO:0022038) |
| 0.0 | 0.7 | GO:0007528 | neuromuscular junction development(GO:0007528) |
| 0.0 | 0.6 | GO:0006103 | 2-oxoglutarate metabolic process(GO:0006103) |
| 0.0 | 0.5 | GO:0034356 | NAD biosynthesis via nicotinamide riboside salvage pathway(GO:0034356) |
| 0.0 | 0.1 | GO:0061051 | positive regulation of cell growth involved in cardiac muscle cell development(GO:0061051) |
| 0.0 | 0.8 | GO:0051496 | positive regulation of stress fiber assembly(GO:0051496) |
| 0.0 | 0.6 | GO:0006582 | melanin metabolic process(GO:0006582) |
| 0.0 | 1.3 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
| 0.0 | 0.3 | GO:0031338 | regulation of vesicle fusion(GO:0031338) |
| 0.0 | 0.2 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
| 0.0 | 0.6 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
| 0.0 | 0.1 | GO:2000286 | receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
| 0.0 | 0.6 | GO:0030728 | ovulation(GO:0030728) |
| 0.0 | 0.1 | GO:0035385 | Roundabout signaling pathway(GO:0035385) |
| 0.0 | 0.2 | GO:1902969 | mitotic DNA replication(GO:1902969) |
| 0.0 | 0.3 | GO:0019919 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) |
| 0.0 | 0.5 | GO:0048070 | regulation of developmental pigmentation(GO:0048070) |
| 0.0 | 0.1 | GO:0036018 | cellular response to erythropoietin(GO:0036018) erythropoietin-mediated signaling pathway(GO:0038162) |
| 0.0 | 0.1 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
| 0.0 | 0.4 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
| 0.0 | 0.1 | GO:1903412 | response to bile acid(GO:1903412) |
| 0.0 | 0.1 | GO:0002625 | regulation of T cell antigen processing and presentation(GO:0002625) |
| 0.0 | 0.0 | GO:0046833 | positive regulation of nucleobase-containing compound transport(GO:0032241) positive regulation of RNA export from nucleus(GO:0046833) |
| 0.0 | 0.1 | GO:0016240 | autophagosome docking(GO:0016240) |
| 0.0 | 0.1 | GO:0045776 | negative regulation of blood pressure(GO:0045776) |
| 0.0 | 0.1 | GO:0006311 | meiotic gene conversion(GO:0006311) |
| 0.0 | 0.5 | GO:0006309 | apoptotic DNA fragmentation(GO:0006309) |
| 0.0 | 1.2 | GO:0032259 | methylation(GO:0032259) |
| 0.0 | 0.1 | GO:0090071 | negative regulation of ribosome biogenesis(GO:0090071) |
| 0.0 | 0.3 | GO:0048599 | oocyte development(GO:0048599) |
| 0.0 | 0.1 | GO:2000253 | positive regulation of feeding behavior(GO:2000253) |
| 0.0 | 0.1 | GO:0099525 | presynaptic dense core granule exocytosis(GO:0099525) |
| 0.0 | 0.5 | GO:0006450 | regulation of translational fidelity(GO:0006450) |
| 0.0 | 0.3 | GO:0097264 | self proteolysis(GO:0097264) |
| 0.0 | 0.2 | GO:0006975 | DNA damage induced protein phosphorylation(GO:0006975) |
| 0.0 | 0.1 | GO:0051446 | positive regulation of meiotic nuclear division(GO:0045836) positive regulation of meiotic cell cycle(GO:0051446) |
| 0.0 | 0.5 | GO:0016572 | histone phosphorylation(GO:0016572) |
| 0.0 | 0.3 | GO:0000722 | telomere maintenance via recombination(GO:0000722) |
| 0.0 | 0.5 | GO:0035518 | histone H2A monoubiquitination(GO:0035518) |
| 0.0 | 0.1 | GO:0060373 | regulation of ventricular cardiac muscle cell membrane depolarization(GO:0060373) membrane depolarization during SA node cell action potential(GO:0086046) |
| 0.0 | 0.5 | GO:2000179 | positive regulation of neural precursor cell proliferation(GO:2000179) |
| 0.0 | 0.3 | GO:1904871 | regulation of protein localization to Cajal body(GO:1904869) positive regulation of protein localization to Cajal body(GO:1904871) |
| 0.0 | 3.6 | GO:0007173 | epidermal growth factor receptor signaling pathway(GO:0007173) |
| 0.0 | 0.1 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
| 0.0 | 1.2 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
| 0.0 | 2.5 | GO:2000134 | negative regulation of G1/S transition of mitotic cell cycle(GO:2000134) |
| 0.0 | 0.8 | GO:0007264 | small GTPase mediated signal transduction(GO:0007264) |
| 0.0 | 0.5 | GO:0071451 | cellular response to oxygen radical(GO:0071450) cellular response to superoxide(GO:0071451) |
| 0.0 | 1.1 | GO:0051260 | protein homooligomerization(GO:0051260) |
| 0.0 | 1.0 | GO:0014047 | glutamate secretion(GO:0014047) |
| 0.0 | 0.3 | GO:0007130 | synaptonemal complex assembly(GO:0007130) |
| 0.0 | 1.6 | GO:0007602 | phototransduction(GO:0007602) |
| 0.0 | 0.2 | GO:0009249 | protein lipoylation(GO:0009249) |
| 0.0 | 0.5 | GO:0045116 | protein neddylation(GO:0045116) |
| 0.0 | 0.3 | GO:0000712 | resolution of meiotic recombination intermediates(GO:0000712) |
| 0.0 | 0.6 | GO:0042267 | natural killer cell mediated cytotoxicity(GO:0042267) |
| 0.0 | 0.0 | GO:0035811 | negative regulation of urine volume(GO:0035811) |
| 0.0 | 0.1 | GO:0048820 | hair follicle maturation(GO:0048820) |
| 0.0 | 0.6 | GO:0060314 | regulation of ryanodine-sensitive calcium-release channel activity(GO:0060314) |
| 0.0 | 0.1 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
| 0.0 | 0.7 | GO:0006635 | fatty acid beta-oxidation(GO:0006635) |
| 0.0 | 0.2 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
| 0.0 | 0.5 | GO:1903859 | regulation of dendrite extension(GO:1903859) positive regulation of dendrite extension(GO:1903861) |
| 0.0 | 0.1 | GO:2001184 | positive regulation of interleukin-12 secretion(GO:2001184) |
| 0.0 | 0.3 | GO:0042749 | regulation of circadian sleep/wake cycle(GO:0042749) regulation of circadian sleep/wake cycle, sleep(GO:0045187) |
| 0.0 | 1.9 | GO:0010923 | negative regulation of phosphatase activity(GO:0010923) |
| 0.0 | 0.1 | GO:0044537 | regulation of circulating fibrinogen levels(GO:0044537) |
| 0.0 | 0.8 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) |
| 0.0 | 1.1 | GO:0016266 | O-glycan processing(GO:0016266) |
| 0.0 | 0.4 | GO:0051966 | regulation of synaptic transmission, glutamatergic(GO:0051966) |
| 0.0 | 0.4 | GO:0000060 | protein import into nucleus, translocation(GO:0000060) |
| 0.0 | 0.0 | GO:0007005 | mitochondrion organization(GO:0007005) |
| 0.0 | 0.3 | GO:0001502 | cartilage condensation(GO:0001502) |
| 0.0 | 0.1 | GO:0010587 | miRNA catabolic process(GO:0010587) |
| 0.0 | 0.6 | GO:0000245 | spliceosomal complex assembly(GO:0000245) |
| 0.0 | 0.1 | GO:0016973 | poly(A)+ mRNA export from nucleus(GO:0016973) |
| 0.0 | 0.7 | GO:0007189 | adenylate cyclase-activating G-protein coupled receptor signaling pathway(GO:0007189) |
| 0.0 | 0.1 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
| 0.0 | 0.4 | GO:0098927 | vesicle-mediated transport between endosomal compartments(GO:0098927) |
| 0.0 | 0.1 | GO:0043606 | formate metabolic process(GO:0015942) histidine catabolic process to glutamate and formamide(GO:0019556) histidine catabolic process to glutamate and formate(GO:0019557) formamide metabolic process(GO:0043606) |
| 0.0 | 0.1 | GO:1903358 | regulation of Golgi organization(GO:1903358) |
| 0.0 | 0.5 | GO:0030038 | contractile actin filament bundle assembly(GO:0030038) stress fiber assembly(GO:0043149) |
| 0.0 | 2.2 | GO:0009408 | response to heat(GO:0009408) |
| 0.0 | 0.2 | GO:0015718 | monocarboxylic acid transport(GO:0015718) |
| 0.0 | 0.9 | GO:0042633 | molting cycle(GO:0042303) hair cycle(GO:0042633) |
| 0.0 | 0.5 | GO:0035418 | protein localization to synapse(GO:0035418) |
| 0.0 | 0.3 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
| 0.0 | 0.1 | GO:0039529 | RIG-I signaling pathway(GO:0039529) |
| 0.0 | 0.2 | GO:0031063 | regulation of histone deacetylation(GO:0031063) |
| 0.0 | 1.9 | GO:1902600 | hydrogen ion transmembrane transport(GO:1902600) |
| 0.0 | 0.3 | GO:0042391 | regulation of membrane potential(GO:0042391) |
| 0.0 | 0.2 | GO:0051764 | actin crosslink formation(GO:0051764) |
| 0.0 | 0.4 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
| 0.0 | 0.3 | GO:0051904 | melanosome transport(GO:0032402) pigment granule transport(GO:0051904) |
| 0.0 | 0.1 | GO:0060445 | branching involved in salivary gland morphogenesis(GO:0060445) |
| 0.0 | 0.2 | GO:0042340 | keratan sulfate catabolic process(GO:0042340) |
| 0.0 | 0.2 | GO:0042730 | fibrinolysis(GO:0042730) |
| 0.0 | 0.1 | GO:0002526 | acute inflammatory response(GO:0002526) acute-phase response(GO:0006953) |
| 0.0 | 0.3 | GO:0048025 | negative regulation of mRNA splicing, via spliceosome(GO:0048025) |
| 0.0 | 0.4 | GO:2000249 | regulation of actin cytoskeleton reorganization(GO:2000249) |
| 0.0 | 0.1 | GO:0032740 | positive regulation of interleukin-17 production(GO:0032740) |
| 0.0 | 0.3 | GO:2000678 | negative regulation of transcription regulatory region DNA binding(GO:2000678) |
| 0.0 | 0.3 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
| 0.0 | 0.1 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
| 0.0 | 0.2 | GO:0042135 | neurotransmitter catabolic process(GO:0042135) |
| 0.0 | 1.2 | GO:0006687 | glycosphingolipid metabolic process(GO:0006687) |
| 0.0 | 0.1 | GO:0060263 | regulation of respiratory burst(GO:0060263) |
| 0.0 | 0.2 | GO:0090090 | negative regulation of canonical Wnt signaling pathway(GO:0090090) |
| 0.0 | 0.2 | GO:0015671 | oxygen transport(GO:0015671) |
| 0.0 | 0.3 | GO:0000470 | maturation of LSU-rRNA(GO:0000470) |
| 0.0 | 1.2 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
| 0.0 | 0.3 | GO:0019985 | translesion synthesis(GO:0019985) |
| 0.0 | 0.3 | GO:0048147 | negative regulation of fibroblast proliferation(GO:0048147) |
| 0.0 | 0.2 | GO:0006346 | methylation-dependent chromatin silencing(GO:0006346) |
| 0.0 | 0.5 | GO:0002250 | adaptive immune response(GO:0002250) |
| 0.0 | 0.1 | GO:0015860 | purine nucleoside transmembrane transport(GO:0015860) |
Gene overrepresentation in cellular_component category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 3.0 | 21.3 | GO:0097209 | epidermal lamellar body(GO:0097209) |
| 1.4 | 4.3 | GO:0005607 | laminin-2 complex(GO:0005607) |
| 1.0 | 2.9 | GO:0043511 | inhibin complex(GO:0043511) inhibin A complex(GO:0043512) |
| 0.7 | 5.9 | GO:0005610 | laminin-5 complex(GO:0005610) |
| 0.7 | 2.8 | GO:0071062 | alphav-beta3 integrin-vitronectin complex(GO:0071062) |
| 0.5 | 1.6 | GO:0097447 | dendritic tree(GO:0097447) |
| 0.4 | 2.2 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
| 0.4 | 4.3 | GO:0000796 | condensin complex(GO:0000796) |
| 0.4 | 2.5 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
| 0.4 | 2.0 | GO:0020016 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
| 0.4 | 1.1 | GO:0009330 | DNA topoisomerase complex (ATP-hydrolyzing)(GO:0009330) |
| 0.4 | 3.2 | GO:0030868 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
| 0.4 | 9.2 | GO:0042627 | chylomicron(GO:0042627) |
| 0.4 | 1.1 | GO:0042022 | interleukin-12 receptor complex(GO:0042022) |
| 0.3 | 2.7 | GO:0071144 | SMAD2-SMAD3 protein complex(GO:0071144) |
| 0.3 | 7.8 | GO:0005614 | interstitial matrix(GO:0005614) |
| 0.3 | 1.9 | GO:0070381 | endosome to plasma membrane transport vesicle(GO:0070381) |
| 0.3 | 2.7 | GO:0071546 | pi-body(GO:0071546) |
| 0.3 | 0.9 | GO:1990032 | parallel fiber(GO:1990032) |
| 0.3 | 0.8 | GO:0035841 | new growing cell tip(GO:0035841) |
| 0.3 | 9.8 | GO:0035371 | microtubule plus-end(GO:0035371) |
| 0.2 | 2.5 | GO:0070852 | cell body fiber(GO:0070852) |
| 0.2 | 1.5 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
| 0.2 | 4.4 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
| 0.2 | 0.7 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
| 0.2 | 6.2 | GO:0031528 | microvillus membrane(GO:0031528) |
| 0.2 | 4.8 | GO:0005922 | connexon complex(GO:0005922) |
| 0.2 | 0.8 | GO:0005694 | chromosome(GO:0005694) |
| 0.2 | 0.9 | GO:0002081 | outer acrosomal membrane(GO:0002081) |
| 0.2 | 1.3 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
| 0.2 | 2.8 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
| 0.2 | 0.5 | GO:0044354 | pinosome(GO:0044352) macropinosome(GO:0044354) |
| 0.2 | 2.6 | GO:0030056 | hemidesmosome(GO:0030056) |
| 0.1 | 0.4 | GO:0034665 | integrin alpha1-beta1 complex(GO:0034665) |
| 0.1 | 0.7 | GO:0001405 | presequence translocase-associated import motor(GO:0001405) |
| 0.1 | 0.6 | GO:0072379 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
| 0.1 | 0.9 | GO:0043541 | UDP-N-acetylglucosamine transferase complex(GO:0043541) |
| 0.1 | 7.5 | GO:0001533 | cornified envelope(GO:0001533) |
| 0.1 | 0.2 | GO:0072536 | interleukin-23 receptor complex(GO:0072536) |
| 0.1 | 1.7 | GO:0030008 | TRAPP complex(GO:0030008) |
| 0.1 | 0.6 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
| 0.1 | 0.5 | GO:0030906 | retromer, cargo-selective complex(GO:0030906) |
| 0.1 | 0.3 | GO:0035189 | Rb-E2F complex(GO:0035189) |
| 0.1 | 2.6 | GO:0001891 | phagocytic cup(GO:0001891) |
| 0.1 | 0.9 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
| 0.1 | 0.6 | GO:0032154 | cell division site(GO:0032153) cleavage furrow(GO:0032154) cell division site part(GO:0032155) cell surface furrow(GO:0097610) |
| 0.1 | 1.2 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
| 0.1 | 4.8 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
| 0.1 | 1.1 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
| 0.1 | 0.5 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
| 0.1 | 0.6 | GO:0036449 | microtubule minus-end(GO:0036449) |
| 0.1 | 3.6 | GO:0051233 | spindle midzone(GO:0051233) |
| 0.1 | 0.7 | GO:0070847 | core mediator complex(GO:0070847) |
| 0.1 | 0.7 | GO:0043219 | lateral loop(GO:0043219) |
| 0.1 | 11.3 | GO:0035578 | azurophil granule lumen(GO:0035578) |
| 0.1 | 0.3 | GO:0071821 | FANCM-MHF complex(GO:0071821) |
| 0.1 | 0.9 | GO:0035749 | myelin sheath adaxonal region(GO:0035749) |
| 0.1 | 2.3 | GO:0005639 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) |
| 0.1 | 1.6 | GO:0097512 | cardiac myofibril(GO:0097512) |
| 0.1 | 5.9 | GO:0031907 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
| 0.1 | 1.0 | GO:0031298 | replication fork protection complex(GO:0031298) |
| 0.1 | 0.3 | GO:0097679 | symbiont-containing vacuole(GO:0020003) symbiont-containing vacuole membrane(GO:0020005) other organism cytoplasm(GO:0097679) |
| 0.1 | 0.3 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
| 0.1 | 3.2 | GO:0030673 | axolemma(GO:0030673) |
| 0.1 | 1.4 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
| 0.1 | 0.5 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
| 0.1 | 2.4 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
| 0.1 | 0.2 | GO:0005588 | collagen type V trimer(GO:0005588) |
| 0.1 | 1.5 | GO:0000800 | lateral element(GO:0000800) |
| 0.1 | 0.8 | GO:0033202 | Ino80 complex(GO:0031011) DNA helicase complex(GO:0033202) |
| 0.1 | 1.2 | GO:0030897 | HOPS complex(GO:0030897) |
| 0.1 | 0.4 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
| 0.1 | 1.1 | GO:0045180 | basal cortex(GO:0045180) |
| 0.1 | 1.0 | GO:0044327 | dendritic spine head(GO:0044327) |
| 0.1 | 0.4 | GO:0005876 | spindle microtubule(GO:0005876) |
| 0.1 | 0.6 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
| 0.1 | 0.7 | GO:0005869 | dynactin complex(GO:0005869) |
| 0.1 | 0.2 | GO:0030895 | apolipoprotein B mRNA editing enzyme complex(GO:0030895) |
| 0.1 | 0.4 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
| 0.1 | 1.3 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
| 0.1 | 0.4 | GO:0097129 | cyclin D2-CDK4 complex(GO:0097129) |
| 0.1 | 2.3 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
| 0.1 | 0.3 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
| 0.1 | 9.7 | GO:0005882 | intermediate filament(GO:0005882) |
| 0.1 | 0.6 | GO:0016589 | NURF complex(GO:0016589) |
| 0.1 | 1.5 | GO:0001527 | microfibril(GO:0001527) fibril(GO:0043205) |
| 0.1 | 1.0 | GO:0042555 | MCM complex(GO:0042555) |
| 0.1 | 1.5 | GO:0031105 | septin complex(GO:0031105) |
| 0.1 | 0.8 | GO:0031252 | cell leading edge(GO:0031252) |
| 0.1 | 3.7 | GO:0043198 | dendritic shaft(GO:0043198) |
| 0.1 | 0.3 | GO:0035061 | interchromatin granule(GO:0035061) |
| 0.0 | 0.6 | GO:0005642 | annulate lamellae(GO:0005642) |
| 0.0 | 1.2 | GO:0097228 | sperm principal piece(GO:0097228) |
| 0.0 | 0.3 | GO:0032311 | angiogenin-PRI complex(GO:0032311) |
| 0.0 | 2.2 | GO:0000922 | spindle pole(GO:0000922) |
| 0.0 | 0.3 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
| 0.0 | 2.1 | GO:0048786 | presynaptic active zone(GO:0048786) |
| 0.0 | 0.4 | GO:0005955 | calcineurin complex(GO:0005955) |
| 0.0 | 0.4 | GO:0032009 | early phagosome(GO:0032009) |
| 0.0 | 0.9 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) ripoptosome(GO:0097342) |
| 0.0 | 2.3 | GO:0016328 | lateral plasma membrane(GO:0016328) |
| 0.0 | 0.1 | GO:0000229 | cytoplasmic chromosome(GO:0000229) |
| 0.0 | 0.5 | GO:0016600 | flotillin complex(GO:0016600) |
| 0.0 | 0.3 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
| 0.0 | 0.5 | GO:0031526 | brush border membrane(GO:0031526) |
| 0.0 | 0.2 | GO:0001520 | outer dense fiber(GO:0001520) |
| 0.0 | 1.4 | GO:0005640 | nuclear outer membrane(GO:0005640) |
| 0.0 | 0.1 | GO:0038039 | G-protein coupled receptor heterodimeric complex(GO:0038039) |
| 0.0 | 1.2 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
| 0.0 | 3.3 | GO:0031093 | platelet alpha granule lumen(GO:0031093) |
| 0.0 | 0.4 | GO:0044232 | organelle membrane contact site(GO:0044232) |
| 0.0 | 0.1 | GO:0098839 | postsynaptic density membrane(GO:0098839) |
| 0.0 | 0.2 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
| 0.0 | 1.9 | GO:0031941 | filamentous actin(GO:0031941) |
| 0.0 | 0.3 | GO:0097486 | multivesicular body lumen(GO:0097486) |
| 0.0 | 0.8 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
| 0.0 | 0.2 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
| 0.0 | 1.6 | GO:0002102 | podosome(GO:0002102) |
| 0.0 | 2.7 | GO:0042734 | presynaptic membrane(GO:0042734) |
| 0.0 | 1.1 | GO:0031258 | lamellipodium membrane(GO:0031258) |
| 0.0 | 0.5 | GO:0005840 | ribosome(GO:0005840) |
| 0.0 | 0.2 | GO:0016272 | prefoldin complex(GO:0016272) |
| 0.0 | 1.9 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
| 0.0 | 2.5 | GO:0001725 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
| 0.0 | 2.0 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
| 0.0 | 1.8 | GO:0016459 | myosin complex(GO:0016459) |
| 0.0 | 0.4 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
| 0.0 | 0.1 | GO:0030663 | COPI-coated vesicle membrane(GO:0030663) |
| 0.0 | 0.3 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
| 0.0 | 0.4 | GO:0031045 | dense core granule(GO:0031045) |
| 0.0 | 0.3 | GO:0005833 | hemoglobin complex(GO:0005833) |
| 0.0 | 1.6 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
| 0.0 | 2.2 | GO:0005901 | caveola(GO:0005901) |
| 0.0 | 0.9 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
| 0.0 | 0.4 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
| 0.0 | 0.8 | GO:0002080 | acrosomal membrane(GO:0002080) |
| 0.0 | 0.5 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
| 0.0 | 3.3 | GO:0030117 | membrane coat(GO:0030117) coated membrane(GO:0048475) |
| 0.0 | 0.1 | GO:0043293 | apoptosome(GO:0043293) |
| 0.0 | 1.4 | GO:0031201 | SNARE complex(GO:0031201) |
| 0.0 | 0.6 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
| 0.0 | 8.5 | GO:0030424 | axon(GO:0030424) |
| 0.0 | 1.0 | GO:0005637 | nuclear inner membrane(GO:0005637) |
| 0.0 | 0.3 | GO:0005921 | gap junction(GO:0005921) |
| 0.0 | 1.1 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
| 0.0 | 0.1 | GO:0016938 | kinesin I complex(GO:0016938) |
| 0.0 | 0.3 | GO:0017119 | Golgi transport complex(GO:0017119) |
| 0.0 | 0.2 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
| 0.0 | 0.3 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
| 0.0 | 1.4 | GO:0031672 | A band(GO:0031672) |
| 0.0 | 0.2 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
| 0.0 | 0.7 | GO:0031304 | intrinsic component of mitochondrial inner membrane(GO:0031304) integral component of mitochondrial inner membrane(GO:0031305) |
| 0.0 | 0.8 | GO:0000314 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
| 0.0 | 2.6 | GO:0044306 | neuron projection terminus(GO:0044306) |
| 0.0 | 0.9 | GO:0034707 | chloride channel complex(GO:0034707) |
| 0.0 | 0.9 | GO:0097542 | ciliary tip(GO:0097542) |
| 0.0 | 0.3 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
| 0.0 | 8.1 | GO:0015629 | actin cytoskeleton(GO:0015629) |
| 0.0 | 1.6 | GO:0032587 | ruffle membrane(GO:0032587) |
| 0.0 | 0.8 | GO:0005871 | kinesin complex(GO:0005871) |
| 0.0 | 0.2 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
| 0.0 | 3.3 | GO:0060076 | excitatory synapse(GO:0060076) |
| 0.0 | 0.3 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
| 0.0 | 1.2 | GO:0000794 | condensed nuclear chromosome(GO:0000794) |
| 0.0 | 0.8 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
| 0.0 | 1.2 | GO:0045211 | postsynaptic membrane(GO:0045211) |
| 0.0 | 0.2 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
| 0.0 | 0.2 | GO:0030285 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
| 0.0 | 0.3 | GO:0019897 | extrinsic component of plasma membrane(GO:0019897) |
| 0.0 | 0.2 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
| 0.0 | 0.1 | GO:0000333 | telomerase catalytic core complex(GO:0000333) |
| 0.0 | 0.2 | GO:0035102 | PRC1 complex(GO:0035102) |
| 0.0 | 1.6 | GO:0030027 | lamellipodium(GO:0030027) |
| 0.0 | 1.1 | GO:0031012 | extracellular matrix(GO:0031012) |
| 0.0 | 0.1 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
| 0.0 | 0.1 | GO:0000151 | ubiquitin ligase complex(GO:0000151) |
| 0.0 | 3.0 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
| 0.0 | 0.1 | GO:0033391 | chromatoid body(GO:0033391) |
| 0.0 | 5.2 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
| 0.0 | 1.1 | GO:0042383 | sarcolemma(GO:0042383) |
| 0.0 | 2.7 | GO:0030425 | dendrite(GO:0030425) |
| 0.0 | 1.5 | GO:0000793 | condensed chromosome(GO:0000793) |
| 0.0 | 0.2 | GO:0097346 | INO80-type complex(GO:0097346) |
| 0.0 | 0.3 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
| 0.0 | 0.1 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
Gene overrepresentation in molecular_function category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.9 | 5.7 | GO:0070506 | high-density lipoprotein particle receptor activity(GO:0070506) |
| 1.1 | 3.4 | GO:0002113 | interleukin-33 binding(GO:0002113) |
| 1.1 | 4.4 | GO:0018685 | alkane 1-monooxygenase activity(GO:0018685) |
| 1.0 | 2.9 | GO:0070699 | type II activin receptor binding(GO:0070699) |
| 0.9 | 4.6 | GO:0004066 | asparagine synthase (glutamine-hydrolyzing) activity(GO:0004066) |
| 0.9 | 9.2 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
| 0.9 | 8.5 | GO:0019237 | centromeric DNA binding(GO:0019237) |
| 0.8 | 2.4 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) procollagen glucosyltransferase activity(GO:0033823) |
| 0.7 | 3.0 | GO:0003938 | IMP dehydrogenase activity(GO:0003938) |
| 0.7 | 3.0 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
| 0.6 | 1.7 | GO:0051499 | D-aminoacyl-tRNA deacylase activity(GO:0051499) D-tyrosyl-tRNA(Tyr) deacylase activity(GO:0051500) |
| 0.5 | 1.6 | GO:0004019 | adenylosuccinate synthase activity(GO:0004019) |
| 0.5 | 1.6 | GO:0033878 | hormone-sensitive lipase activity(GO:0033878) |
| 0.5 | 2.7 | GO:0031962 | mineralocorticoid receptor binding(GO:0031962) |
| 0.5 | 2.6 | GO:0017159 | pantetheine hydrolase activity(GO:0017159) |
| 0.5 | 4.8 | GO:0102337 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
| 0.5 | 4.7 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
| 0.5 | 1.5 | GO:0004938 | alpha2-adrenergic receptor activity(GO:0004938) |
| 0.4 | 0.9 | GO:0015250 | water channel activity(GO:0015250) |
| 0.4 | 2.2 | GO:0016728 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
| 0.4 | 5.2 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
| 0.4 | 7.2 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
| 0.4 | 1.2 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
| 0.4 | 1.9 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
| 0.4 | 1.1 | GO:0061505 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
| 0.4 | 1.1 | GO:0004913 | interleukin-4 receptor activity(GO:0004913) |
| 0.4 | 2.2 | GO:0015180 | L-alanine transmembrane transporter activity(GO:0015180) L-cystine transmembrane transporter activity(GO:0015184) alanine transmembrane transporter activity(GO:0022858) |
| 0.4 | 1.1 | GO:0008518 | reduced folate carrier activity(GO:0008518) |
| 0.4 | 1.1 | GO:0036487 | nitric-oxide synthase inhibitor activity(GO:0036487) |
| 0.4 | 1.1 | GO:0016517 | interleukin-12 receptor activity(GO:0016517) |
| 0.4 | 1.8 | GO:0080019 | fatty-acyl-CoA reductase (alcohol-forming) activity(GO:0080019) |
| 0.3 | 1.7 | GO:0004161 | dimethylallyltranstransferase activity(GO:0004161) geranyltranstransferase activity(GO:0004337) |
| 0.3 | 1.7 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
| 0.3 | 1.7 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
| 0.3 | 6.8 | GO:0050786 | RAGE receptor binding(GO:0050786) |
| 0.3 | 1.0 | GO:0017082 | mineralocorticoid receptor activity(GO:0017082) |
| 0.3 | 1.3 | GO:0004517 | nitric-oxide synthase activity(GO:0004517) |
| 0.3 | 1.6 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
| 0.3 | 1.3 | GO:0033765 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) steroid dehydrogenase activity, acting on the CH-CH group of donors(GO:0033765) cholestenone 5-alpha-reductase activity(GO:0047751) |
| 0.3 | 1.2 | GO:0004365 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
| 0.3 | 4.4 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
| 0.3 | 1.8 | GO:0004647 | phosphoserine phosphatase activity(GO:0004647) |
| 0.3 | 0.9 | GO:0031768 | ghrelin receptor binding(GO:0031768) |
| 0.3 | 0.8 | GO:0004817 | cysteine-tRNA ligase activity(GO:0004817) |
| 0.3 | 2.7 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
| 0.3 | 0.8 | GO:0008386 | cholesterol monooxygenase (side-chain-cleaving) activity(GO:0008386) |
| 0.3 | 0.8 | GO:0008798 | beta-aspartyl-peptidase activity(GO:0008798) |
| 0.3 | 0.8 | GO:0038131 | neuregulin receptor activity(GO:0038131) |
| 0.2 | 3.0 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
| 0.2 | 0.7 | GO:0004392 | heme oxygenase (decyclizing) activity(GO:0004392) |
| 0.2 | 1.7 | GO:0061575 | cyclin-dependent protein serine/threonine kinase activator activity(GO:0061575) |
| 0.2 | 1.6 | GO:1990254 | keratin filament binding(GO:1990254) |
| 0.2 | 3.0 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
| 0.2 | 1.3 | GO:0004771 | sterol esterase activity(GO:0004771) |
| 0.2 | 0.6 | GO:0004174 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
| 0.2 | 1.1 | GO:0004489 | methylenetetrahydrofolate reductase (NAD(P)H) activity(GO:0004489) |
| 0.2 | 0.6 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
| 0.2 | 2.8 | GO:0035256 | G-protein coupled glutamate receptor binding(GO:0035256) |
| 0.2 | 3.8 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
| 0.2 | 2.1 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
| 0.2 | 1.1 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
| 0.2 | 0.7 | GO:0003985 | acetyl-CoA C-acetyltransferase activity(GO:0003985) |
| 0.2 | 1.5 | GO:0004873 | asialoglycoprotein receptor activity(GO:0004873) |
| 0.2 | 0.6 | GO:0004962 | endothelin receptor activity(GO:0004962) |
| 0.2 | 0.6 | GO:0050698 | proteoglycan sulfotransferase activity(GO:0050698) |
| 0.2 | 0.7 | GO:0050509 | N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity(GO:0050509) |
| 0.2 | 1.0 | GO:0045174 | oxidoreductase activity, acting on a sulfur group of donors, quinone or similar compound as acceptor(GO:0016672) glutathione dehydrogenase (ascorbate) activity(GO:0045174) methylarsonate reductase activity(GO:0050610) |
| 0.2 | 2.2 | GO:0032027 | myosin light chain binding(GO:0032027) |
| 0.2 | 1.0 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
| 0.2 | 0.5 | GO:0017130 | poly(C) RNA binding(GO:0017130) |
| 0.2 | 0.5 | GO:1990259 | protein-glutamine N-methyltransferase activity(GO:0036009) histone-glutamine methyltransferase activity(GO:1990259) |
| 0.2 | 1.0 | GO:0004630 | phospholipase D activity(GO:0004630) |
| 0.2 | 1.5 | GO:0086083 | cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communication(GO:0086083) |
| 0.2 | 0.6 | GO:0015563 | uptake transmembrane transporter activity(GO:0015563) |
| 0.2 | 0.5 | GO:0005111 | type 2 fibroblast growth factor receptor binding(GO:0005111) |
| 0.2 | 0.5 | GO:0004877 | complement component C4b receptor activity(GO:0001861) complement component C3b receptor activity(GO:0004877) |
| 0.2 | 0.6 | GO:0033981 | D-dopachrome decarboxylase activity(GO:0033981) |
| 0.2 | 1.9 | GO:0008199 | ferric iron binding(GO:0008199) |
| 0.2 | 0.5 | GO:0098770 | FBXO family protein binding(GO:0098770) |
| 0.2 | 1.2 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
| 0.2 | 0.5 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
| 0.2 | 0.6 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
| 0.2 | 0.6 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
| 0.1 | 1.6 | GO:0016413 | O-acetyltransferase activity(GO:0016413) |
| 0.1 | 2.7 | GO:0048185 | activin binding(GO:0048185) |
| 0.1 | 1.5 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
| 0.1 | 5.8 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
| 0.1 | 0.7 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
| 0.1 | 0.9 | GO:0039552 | RIG-I binding(GO:0039552) |
| 0.1 | 0.7 | GO:0004692 | cGMP-dependent protein kinase activity(GO:0004692) |
| 0.1 | 0.6 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
| 0.1 | 0.5 | GO:0003963 | RNA-3'-phosphate cyclase activity(GO:0003963) |
| 0.1 | 5.1 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
| 0.1 | 0.4 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
| 0.1 | 0.4 | GO:0016401 | palmitoyl-CoA oxidase activity(GO:0016401) |
| 0.1 | 2.4 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
| 0.1 | 0.5 | GO:0005042 | netrin receptor activity(GO:0005042) |
| 0.1 | 0.5 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
| 0.1 | 5.0 | GO:0030546 | receptor activator activity(GO:0030546) |
| 0.1 | 2.8 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
| 0.1 | 1.5 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
| 0.1 | 0.7 | GO:0045029 | UDP-activated nucleotide receptor activity(GO:0045029) |
| 0.1 | 0.6 | GO:0047237 | glucuronylgalactosylproteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047237) |
| 0.1 | 0.4 | GO:0016603 | glutaminyl-peptide cyclotransferase activity(GO:0016603) |
| 0.1 | 4.0 | GO:0016676 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
| 0.1 | 0.5 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
| 0.1 | 0.8 | GO:0070573 | metallodipeptidase activity(GO:0070573) |
| 0.1 | 0.5 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
| 0.1 | 0.7 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
| 0.1 | 1.8 | GO:0017166 | vinculin binding(GO:0017166) |
| 0.1 | 2.8 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
| 0.1 | 0.2 | GO:0042020 | interleukin-23 binding(GO:0042019) interleukin-23 receptor activity(GO:0042020) |
| 0.1 | 0.5 | GO:0047757 | chondroitin-glucuronate 5-epimerase activity(GO:0047757) |
| 0.1 | 0.3 | GO:0032093 | SAM domain binding(GO:0032093) |
| 0.1 | 0.3 | GO:0050254 | rhodopsin kinase activity(GO:0050254) |
| 0.1 | 0.9 | GO:0003960 | NADPH:quinone reductase activity(GO:0003960) |
| 0.1 | 0.6 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
| 0.1 | 1.8 | GO:0003680 | AT DNA binding(GO:0003680) |
| 0.1 | 2.0 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
| 0.1 | 0.8 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
| 0.1 | 0.8 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
| 0.1 | 0.4 | GO:0030760 | nicotinamide N-methyltransferase activity(GO:0008112) pyridine N-methyltransferase activity(GO:0030760) |
| 0.1 | 10.6 | GO:0008307 | structural constituent of muscle(GO:0008307) |
| 0.1 | 0.8 | GO:0005497 | androgen binding(GO:0005497) |
| 0.1 | 0.3 | GO:0008309 | double-stranded DNA exodeoxyribonuclease activity(GO:0008309) |
| 0.1 | 2.7 | GO:0019206 | nucleoside kinase activity(GO:0019206) |
| 0.1 | 0.4 | GO:0030395 | lactose binding(GO:0030395) |
| 0.1 | 0.4 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
| 0.1 | 0.3 | GO:0045518 | interleukin-22 receptor binding(GO:0045518) |
| 0.1 | 0.3 | GO:0000773 | phosphatidyl-N-methylethanolamine N-methyltransferase activity(GO:0000773) phosphatidylethanolamine N-methyltransferase activity(GO:0004608) phosphatidyl-N-dimethylethanolamine N-methyltransferase activity(GO:0080101) |
| 0.1 | 1.4 | GO:0045028 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
| 0.1 | 0.3 | GO:0015235 | cobalamin transporter activity(GO:0015235) |
| 0.1 | 0.3 | GO:0098640 | integrin binding involved in cell-matrix adhesion(GO:0098640) |
| 0.1 | 27.3 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
| 0.1 | 4.8 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
| 0.1 | 0.7 | GO:0060072 | large conductance calcium-activated potassium channel activity(GO:0060072) |
| 0.1 | 0.9 | GO:0071253 | connexin binding(GO:0071253) |
| 0.1 | 0.1 | GO:0019789 | SUMO transferase activity(GO:0019789) |
| 0.1 | 0.2 | GO:0052642 | lysophosphatidic acid phosphatase activity(GO:0052642) |
| 0.1 | 10.5 | GO:0017048 | Rho GTPase binding(GO:0017048) |
| 0.1 | 0.5 | GO:0050692 | DBD domain binding(GO:0050692) |
| 0.1 | 1.6 | GO:0019841 | retinol binding(GO:0019841) |
| 0.1 | 0.7 | GO:0003917 | DNA topoisomerase activity(GO:0003916) DNA topoisomerase type I activity(GO:0003917) |
| 0.1 | 0.6 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
| 0.1 | 0.7 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
| 0.1 | 0.2 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
| 0.1 | 1.3 | GO:0003688 | DNA replication origin binding(GO:0003688) |
| 0.1 | 0.7 | GO:0097016 | L27 domain binding(GO:0097016) |
| 0.1 | 0.2 | GO:0003943 | N-acetylgalactosamine-4-sulfatase activity(GO:0003943) |
| 0.1 | 0.4 | GO:0098639 | protein binding involved in cell-matrix adhesion(GO:0098634) collagen binding involved in cell-matrix adhesion(GO:0098639) |
| 0.1 | 1.3 | GO:0005243 | gap junction channel activity(GO:0005243) |
| 0.1 | 0.7 | GO:0046923 | ER retention sequence binding(GO:0046923) |
| 0.1 | 1.6 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
| 0.1 | 0.3 | GO:0030107 | HLA-A specific inhibitory MHC class I receptor activity(GO:0030107) |
| 0.1 | 0.5 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
| 0.1 | 1.2 | GO:0004065 | arylsulfatase activity(GO:0004065) |
| 0.1 | 0.8 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
| 0.1 | 1.7 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
| 0.1 | 0.5 | GO:0005353 | fructose transmembrane transporter activity(GO:0005353) |
| 0.1 | 0.6 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
| 0.1 | 0.6 | GO:0033170 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
| 0.1 | 0.3 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
| 0.1 | 1.9 | GO:0031489 | myosin V binding(GO:0031489) |
| 0.1 | 0.3 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
| 0.1 | 0.3 | GO:0019862 | IgA binding(GO:0019862) |
| 0.1 | 0.3 | GO:0070061 | fructose binding(GO:0070061) |
| 0.1 | 0.3 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
| 0.1 | 0.9 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
| 0.1 | 1.5 | GO:0003924 | GTPase activity(GO:0003924) |
| 0.1 | 1.0 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
| 0.1 | 0.3 | GO:0052833 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
| 0.1 | 0.4 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
| 0.1 | 0.9 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
| 0.1 | 1.2 | GO:0070628 | proteasome binding(GO:0070628) |
| 0.1 | 1.0 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
| 0.1 | 0.2 | GO:0035374 | chondroitin sulfate binding(GO:0035374) |
| 0.1 | 0.2 | GO:0003827 | alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity(GO:0003827) |
| 0.1 | 0.6 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
| 0.1 | 0.3 | GO:0034046 | poly(G) binding(GO:0034046) |
| 0.1 | 0.4 | GO:0015501 | glutamate:sodium symporter activity(GO:0015501) |
| 0.1 | 0.4 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
| 0.1 | 1.1 | GO:0043295 | glutathione binding(GO:0043295) |
| 0.1 | 2.2 | GO:0016709 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen(GO:0016709) |
| 0.1 | 0.8 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
| 0.1 | 0.3 | GO:0032450 | maltose alpha-glucosidase activity(GO:0032450) |
| 0.1 | 0.2 | GO:0005330 | dopamine:sodium symporter activity(GO:0005330) |
| 0.1 | 0.3 | GO:0023025 | MHC class Ib protein complex binding(GO:0023025) MHC class Ib protein binding, via antigen binding groove(GO:0023030) |
| 0.1 | 0.5 | GO:0070739 | protein-glutamic acid ligase activity(GO:0070739) |
| 0.0 | 1.6 | GO:0015464 | acetylcholine receptor activity(GO:0015464) |
| 0.0 | 0.4 | GO:0008559 | xenobiotic-transporting ATPase activity(GO:0008559) |
| 0.0 | 0.3 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
| 0.0 | 0.2 | GO:0003774 | motor activity(GO:0003774) |
| 0.0 | 1.4 | GO:0070182 | DNA polymerase binding(GO:0070182) |
| 0.0 | 0.9 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
| 0.0 | 0.3 | GO:1990599 | 3' overhang single-stranded DNA endodeoxyribonuclease activity(GO:1990599) |
| 0.0 | 2.3 | GO:0030552 | cAMP binding(GO:0030552) |
| 0.0 | 0.3 | GO:0005119 | smoothened binding(GO:0005119) |
| 0.0 | 0.6 | GO:0004985 | opioid receptor activity(GO:0004985) |
| 0.0 | 0.2 | GO:0004966 | galanin receptor activity(GO:0004966) |
| 0.0 | 0.3 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
| 0.0 | 2.0 | GO:0005484 | SNAP receptor activity(GO:0005484) |
| 0.0 | 0.9 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
| 0.0 | 0.4 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
| 0.0 | 0.4 | GO:0046920 | alpha-(1->3)-fucosyltransferase activity(GO:0046920) |
| 0.0 | 1.4 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
| 0.0 | 0.7 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
| 0.0 | 0.2 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
| 0.0 | 1.6 | GO:0036002 | pre-mRNA binding(GO:0036002) |
| 0.0 | 0.4 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
| 0.0 | 1.1 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
| 0.0 | 1.0 | GO:0005521 | lamin binding(GO:0005521) |
| 0.0 | 0.4 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
| 0.0 | 0.7 | GO:0008569 | ATP-dependent microtubule motor activity, minus-end-directed(GO:0008569) |
| 0.0 | 0.3 | GO:0050811 | GABA receptor binding(GO:0050811) |
| 0.0 | 4.4 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
| 0.0 | 1.1 | GO:0005504 | fatty acid binding(GO:0005504) |
| 0.0 | 7.3 | GO:0051015 | actin filament binding(GO:0051015) |
| 0.0 | 1.4 | GO:0004622 | lysophospholipase activity(GO:0004622) |
| 0.0 | 7.4 | GO:0017137 | Rab GTPase binding(GO:0017137) |
| 0.0 | 0.7 | GO:0050700 | CARD domain binding(GO:0050700) |
| 0.0 | 0.1 | GO:0023024 | MHC class I protein complex binding(GO:0023024) |
| 0.0 | 0.5 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
| 0.0 | 0.6 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
| 0.0 | 0.5 | GO:0098641 | cadherin binding involved in cell-cell adhesion(GO:0098641) |
| 0.0 | 0.8 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
| 0.0 | 0.3 | GO:0042923 | neuropeptide binding(GO:0042923) |
| 0.0 | 9.5 | GO:0008017 | microtubule binding(GO:0008017) |
| 0.0 | 0.6 | GO:0017070 | U6 snRNA binding(GO:0017070) |
| 0.0 | 0.3 | GO:0019957 | C-C chemokine binding(GO:0019957) |
| 0.0 | 0.9 | GO:0005527 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
| 0.0 | 5.8 | GO:0008201 | heparin binding(GO:0008201) |
| 0.0 | 0.2 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
| 0.0 | 0.1 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
| 0.0 | 0.4 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
| 0.0 | 0.1 | GO:0016428 | tRNA (cytosine-5-)-methyltransferase activity(GO:0016428) |
| 0.0 | 0.3 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
| 0.0 | 0.2 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
| 0.0 | 0.2 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
| 0.0 | 1.2 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
| 0.0 | 0.1 | GO:0016641 | oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor(GO:0016641) |
| 0.0 | 0.3 | GO:0035242 | protein-arginine omega-N asymmetric methyltransferase activity(GO:0035242) |
| 0.0 | 0.6 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
| 0.0 | 0.3 | GO:0008428 | ribonuclease inhibitor activity(GO:0008428) |
| 0.0 | 4.1 | GO:0002020 | protease binding(GO:0002020) |
| 0.0 | 0.7 | GO:0005112 | Notch binding(GO:0005112) |
| 0.0 | 0.2 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
| 0.0 | 0.1 | GO:0004522 | ribonuclease A activity(GO:0004522) |
| 0.0 | 1.5 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
| 0.0 | 0.6 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
| 0.0 | 0.3 | GO:0008097 | 5S rRNA binding(GO:0008097) |
| 0.0 | 0.7 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
| 0.0 | 0.6 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
| 0.0 | 0.3 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
| 0.0 | 0.4 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
| 0.0 | 0.9 | GO:0042169 | SH2 domain binding(GO:0042169) |
| 0.0 | 3.0 | GO:0042826 | histone deacetylase binding(GO:0042826) |
| 0.0 | 0.1 | GO:0005168 | neurotrophin TRKA receptor binding(GO:0005168) |
| 0.0 | 0.2 | GO:0032453 | histone demethylase activity (H3-K4 specific)(GO:0032453) |
| 0.0 | 0.9 | GO:0003823 | antigen binding(GO:0003823) |
| 0.0 | 0.2 | GO:0070700 | BMP receptor binding(GO:0070700) |
| 0.0 | 0.6 | GO:0030551 | cyclic nucleotide binding(GO:0030551) |
| 0.0 | 0.3 | GO:0042043 | neurexin family protein binding(GO:0042043) |
| 0.0 | 0.2 | GO:0016842 | amidine-lyase activity(GO:0016842) |
| 0.0 | 0.1 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
| 0.0 | 0.5 | GO:0032183 | SUMO binding(GO:0032183) |
| 0.0 | 0.3 | GO:0052629 | phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity(GO:0052629) |
| 0.0 | 1.0 | GO:0031593 | polyubiquitin binding(GO:0031593) |
| 0.0 | 2.2 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
| 0.0 | 0.1 | GO:0016618 | hydroxypyruvate reductase activity(GO:0016618) glyoxylate reductase (NADP) activity(GO:0030267) |
| 0.0 | 0.1 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
| 0.0 | 0.6 | GO:0051721 | protein phosphatase 2A binding(GO:0051721) |
| 0.0 | 1.7 | GO:0002039 | p53 binding(GO:0002039) |
| 0.0 | 0.3 | GO:0008301 | DNA binding, bending(GO:0008301) |
| 0.0 | 0.3 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
| 0.0 | 0.5 | GO:0016814 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines(GO:0016814) |
| 0.0 | 0.2 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
| 0.0 | 1.1 | GO:0043022 | ribosome binding(GO:0043022) |
| 0.0 | 1.3 | GO:0003743 | translation initiation factor activity(GO:0003743) |
| 0.0 | 0.3 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
| 0.0 | 0.1 | GO:0016742 | hydroxymethyl-, formyl- and related transferase activity(GO:0016742) |
| 0.0 | 0.5 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
| 0.0 | 0.1 | GO:0005415 | nucleoside:sodium symporter activity(GO:0005415) |
| 0.0 | 0.4 | GO:0016646 | oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor(GO:0016646) |
| 0.0 | 0.4 | GO:0038191 | neuropilin binding(GO:0038191) |
| 0.0 | 0.1 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
| 0.0 | 0.1 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
| 0.0 | 0.1 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
| 0.0 | 0.2 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
| 0.0 | 0.2 | GO:0008656 | cysteine-type endopeptidase activator activity involved in apoptotic process(GO:0008656) |
| 0.0 | 0.8 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
| 0.0 | 0.7 | GO:0004864 | protein phosphatase inhibitor activity(GO:0004864) |
| 0.0 | 0.3 | GO:0004707 | MAP kinase activity(GO:0004707) |
| 0.0 | 0.3 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
| 0.0 | 5.9 | GO:0005525 | GTP binding(GO:0005525) |
| 0.0 | 0.4 | GO:0017091 | AU-rich element binding(GO:0017091) |
| 0.0 | 0.3 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
| 0.0 | 0.5 | GO:0008066 | glutamate receptor activity(GO:0008066) |
| 0.0 | 0.1 | GO:0004875 | complement receptor activity(GO:0004875) |
| 0.0 | 1.3 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
| 0.0 | 0.7 | GO:0035064 | methylated histone binding(GO:0035064) |
| 0.0 | 1.6 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
| 0.0 | 0.5 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
| 0.0 | 0.7 | GO:0044325 | ion channel binding(GO:0044325) |
| 0.0 | 0.4 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
| 0.0 | 0.1 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
| 0.0 | 0.1 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
| 0.0 | 0.2 | GO:0004993 | G-protein coupled serotonin receptor activity(GO:0004993) |
| 0.0 | 0.2 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
| 0.0 | 0.3 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
| 0.0 | 0.5 | GO:0019843 | rRNA binding(GO:0019843) |
| 0.0 | 0.1 | GO:0004331 | 6-phosphofructo-2-kinase activity(GO:0003873) fructose-2,6-bisphosphate 2-phosphatase activity(GO:0004331) |
| 0.0 | 0.2 | GO:0005344 | oxygen transporter activity(GO:0005344) |
| 0.0 | 0.5 | GO:0070063 | RNA polymerase binding(GO:0070063) |
| 0.0 | 0.1 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
Gene overrepresentation in C2:CP category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 0.5 | 11.4 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
| 0.3 | 4.3 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
| 0.2 | 18.4 | PID AURORA B PATHWAY | Aurora B signaling |
| 0.2 | 3.8 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
| 0.1 | 4.3 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
| 0.1 | 6.3 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
| 0.1 | 6.7 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
| 0.1 | 5.7 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
| 0.1 | 0.8 | PID REELIN PATHWAY | Reelin signaling pathway |
| 0.1 | 0.8 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
| 0.1 | 4.6 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
| 0.1 | 2.6 | PID CONE PATHWAY | Visual signal transduction: Cones |
| 0.1 | 1.9 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
| 0.1 | 2.6 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
| 0.1 | 2.6 | PID ALK1 PATHWAY | ALK1 signaling events |
| 0.1 | 9.4 | PID CDC42 PATHWAY | CDC42 signaling events |
| 0.1 | 1.7 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
| 0.1 | 3.3 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
| 0.1 | 1.2 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
| 0.1 | 3.6 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
| 0.1 | 2.9 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
| 0.1 | 0.9 | PID CD40 PATHWAY | CD40/CD40L signaling |
| 0.0 | 0.4 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
| 0.0 | 0.4 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
| 0.0 | 4.4 | ST FAS SIGNALING PATHWAY | Fas Signaling Pathway |
| 0.0 | 2.8 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
| 0.0 | 14.2 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
| 0.0 | 0.6 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
| 0.0 | 1.7 | PID SHP2 PATHWAY | SHP2 signaling |
| 0.0 | 0.4 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
| 0.0 | 0.7 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
| 0.0 | 0.3 | PID S1P S1P1 PATHWAY | S1P1 pathway |
| 0.0 | 1.2 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
| 0.0 | 1.3 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
| 0.0 | 2.3 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
| 0.0 | 0.4 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
| 0.0 | 14.3 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
| 0.0 | 0.7 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
| 0.0 | 2.5 | PID CMYB PATHWAY | C-MYB transcription factor network |
| 0.0 | 0.6 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
| 0.0 | 2.8 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
| 0.0 | 2.0 | PID IL4 2PATHWAY | IL4-mediated signaling events |
| 0.0 | 0.9 | PID ENDOTHELIN PATHWAY | Endothelins |
| 0.0 | 1.1 | PID ATR PATHWAY | ATR signaling pathway |
| 0.0 | 0.8 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
| 0.0 | 0.8 | PID ERBB4 PATHWAY | ErbB4 signaling events |
| 0.0 | 1.1 | PID RAS PATHWAY | Regulation of Ras family activation |
| 0.0 | 1.0 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
| 0.0 | 1.7 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
| 0.0 | 0.3 | PID NECTIN PATHWAY | Nectin adhesion pathway |
| 0.0 | 0.5 | PID AURORA A PATHWAY | Aurora A signaling |
| 0.0 | 1.9 | PID NOTCH PATHWAY | Notch signaling pathway |
| 0.0 | 0.3 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
| 0.0 | 0.4 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
| 0.0 | 0.3 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
| 0.0 | 0.3 | PID IL23 PATHWAY | IL23-mediated signaling events |
| 0.0 | 0.5 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
| 0.0 | 2.0 | PID E2F PATHWAY | E2F transcription factor network |
| 0.0 | 1.3 | PID P73PATHWAY | p73 transcription factor network |
| 0.0 | 0.4 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
| 0.0 | 1.2 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
| 0.0 | 0.3 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
| 0.0 | 0.3 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
| 0.0 | 0.3 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
| 0.0 | 0.4 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
| 0.0 | 0.4 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
| 0.0 | 0.2 | ST G ALPHA I PATHWAY | G alpha i Pathway |
| 0.0 | 0.3 | SIG CHEMOTAXIS | Genes related to chemotaxis |
| 0.0 | 0.2 | ST INTEGRIN SIGNALING PATHWAY | Integrin Signaling Pathway |
| 0.0 | 0.3 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
| 0.0 | 0.6 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
| 0.0 | 0.4 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
| 0.0 | 0.1 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
Gene overrepresentation in C2:CP:REACTOME category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 0.3 | 4.8 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
| 0.2 | 9.2 | REACTOME KINESINS | Genes involved in Kinesins |
| 0.2 | 5.5 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
| 0.2 | 4.8 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
| 0.2 | 2.9 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
| 0.2 | 6.0 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
| 0.2 | 3.8 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
| 0.2 | 4.7 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
| 0.2 | 1.4 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
| 0.2 | 0.8 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
| 0.2 | 4.3 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
| 0.1 | 3.9 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
| 0.1 | 2.4 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
| 0.1 | 1.2 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
| 0.1 | 3.7 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
| 0.1 | 2.2 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
| 0.1 | 1.8 | REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
| 0.1 | 3.4 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
| 0.1 | 14.6 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization |
| 0.1 | 4.2 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
| 0.1 | 1.9 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
| 0.1 | 2.9 | REACTOME G BETA GAMMA SIGNALLING THROUGH PLC BETA | Genes involved in G beta:gamma signalling through PLC beta |
| 0.1 | 1.3 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
| 0.1 | 3.1 | REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |
| 0.1 | 2.3 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
| 0.1 | 1.6 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
| 0.1 | 2.1 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
| 0.1 | 1.6 | REACTOME ACTIVATION OF KAINATE RECEPTORS UPON GLUTAMATE BINDING | Genes involved in Activation of Kainate Receptors upon glutamate binding |
| 0.1 | 2.6 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
| 0.1 | 3.9 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
| 0.1 | 1.2 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
| 0.1 | 2.4 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
| 0.1 | 1.0 | REACTOME POL SWITCHING | Genes involved in Polymerase switching |
| 0.1 | 1.3 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
| 0.1 | 4.3 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
| 0.1 | 2.0 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
| 0.1 | 1.7 | REACTOME RNA POL III CHAIN ELONGATION | Genes involved in RNA Polymerase III Chain Elongation |
| 0.1 | 3.8 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
| 0.1 | 2.1 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
| 0.1 | 0.3 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
| 0.1 | 2.1 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
| 0.1 | 0.8 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
| 0.1 | 0.2 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
| 0.1 | 0.8 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
| 0.1 | 4.4 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
| 0.1 | 2.5 | REACTOME G1 PHASE | Genes involved in G1 Phase |
| 0.1 | 1.6 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
| 0.1 | 0.9 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
| 0.0 | 1.0 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
| 0.0 | 0.5 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
| 0.0 | 3.6 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
| 0.0 | 0.9 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
| 0.0 | 3.4 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
| 0.0 | 2.1 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
| 0.0 | 1.0 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
| 0.0 | 1.7 | REACTOME SIGNAL TRANSDUCTION BY L1 | Genes involved in Signal transduction by L1 |
| 0.0 | 1.6 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
| 0.0 | 0.7 | REACTOME FGFR1 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR1 ligand binding and activation |
| 0.0 | 0.9 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
| 0.0 | 0.3 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
| 0.0 | 1.1 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
| 0.0 | 0.2 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
| 0.0 | 0.8 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
| 0.0 | 0.4 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
| 0.0 | 2.4 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
| 0.0 | 0.3 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
| 0.0 | 2.5 | REACTOME AMINO ACID AND OLIGOPEPTIDE SLC TRANSPORTERS | Genes involved in Amino acid and oligopeptide SLC transporters |
| 0.0 | 0.4 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
| 0.0 | 0.4 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
| 0.0 | 0.5 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
| 0.0 | 0.3 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
| 0.0 | 0.3 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
| 0.0 | 0.8 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
| 0.0 | 0.7 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
| 0.0 | 0.6 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
| 0.0 | 0.6 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
| 0.0 | 0.5 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
| 0.0 | 0.4 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
| 0.0 | 0.2 | REACTOME VIF MEDIATED DEGRADATION OF APOBEC3G | Genes involved in Vif-mediated degradation of APOBEC3G |
| 0.0 | 0.3 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
| 0.0 | 0.3 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
| 0.0 | 0.1 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
| 0.0 | 0.3 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
| 0.0 | 0.4 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
| 0.0 | 0.5 | REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
| 0.0 | 0.4 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
| 0.0 | 2.9 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
| 0.0 | 0.2 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
| 0.0 | 0.4 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
| 0.0 | 0.1 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
| 0.0 | 0.5 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
| 0.0 | 3.1 | REACTOME G ALPHA Q SIGNALLING EVENTS | Genes involved in G alpha (q) signalling events |
| 0.0 | 0.8 | REACTOME CHONDROITIN SULFATE DERMATAN SULFATE METABOLISM | Genes involved in Chondroitin sulfate/dermatan sulfate metabolism |
| 0.0 | 0.6 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
| 0.0 | 0.4 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
| 0.0 | 0.5 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
| 0.0 | 0.6 | REACTOME PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
| 0.0 | 0.5 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
| 0.0 | 0.2 | REACTOME OPSINS | Genes involved in Opsins |
| 0.0 | 0.2 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
| 0.0 | 0.2 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
| 0.0 | 0.3 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
| 0.0 | 0.3 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
| 0.0 | 1.4 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
| 0.0 | 0.5 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |